hg_40204.1

Basic information about the TSS

---

TSS ID: hg_40204.1 Species: human Chr: chr3		Start: 184363387 End: 184363420 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000452961.5 U37689 Z49199 Distance: 0 GeneID: 5437 HGNC/MGI_ID: HGNC:9195 UniProt_ID: P52434

Gene_name: RNA polymerase II, I and III subunit H Gene_symbol: POLR2H Gene_synonyms: RPB8 Gene_source: HGNC:9195

TATA-Box annotation

---

Distance to TSS:	43
Nearest PromoterID:	NM_001278698
Entrez ID:	5437
Nearest Unigene:	Hs.432574
Nearest Refseq:	NM_006232
Nearest Ensembl:	ENSG00000163882
Gene Name:	RNA polymerase II, I and III subunit H
Gene Alias:	RPABC3|RPB17|RPB8
Gene Description:	RNA polymerase II subunit H
Gene Type:	protein-coding
CpG%:	0.105
GC%:	0.651741
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@POLR2H p2@POLR2H p3@POLR2H p5@POLR2H p6@POLR2H p7@POLR2H p10@POLR2H
Sample		p1@POLR2H	p2@POLR2H	p3@POLR2H	p5@POLR2H	p6@POLR2H	p7@POLR2H	p10@POLR2H
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	84.35	70.91	4.29	3.51	2.14	0.97	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	79.71	67.57	5.26	5.06	1.42	1.21	1.42
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	91.24	76.97	3.28	5.21	2.89	1.35	1.35
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	80.25	61.33	2.08	4.57	2.08	1.25	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	85.04	64.34	1.80	4.72	1.57	1.57	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	94.39	66.28	2.71	7.17	1.74	1.36	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	110.90	96.52	4.58	6.10	2.83	2.61	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	105.85	82.35	4.84	5.57	3.88	2.66	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	103.65	75.44	4.70	5.56	1.71	2.35	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	67.82	53.91	6.38	5.22	3.48	2.32	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	69.93	55.78	9.30	3.64	2.83	0.81	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	62.61	53.26	6.10	2.85	1.63	1.22	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	36.11	14.83	1.77	2.42	2.58	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.24	16.54	0.90	1.50	1.95	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.72	15.81	1.10	3.29	1.54	1.54	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	38.73	14.59	0.75	2.51	1.51	1.01	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	37.57	10.92	1.31	1.75	2.18	1.75	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	38.39	15.61	0.00	3.37	0.84	2.11	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	38.92	17.59	1.07	1.60	2.67	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	43.63	17.15	1.35	2.11	2.41	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	38.76	11.76	2.27	1.87	2.14	1.74	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.81	16.05	1.73	1.90	2.07	1.04	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	33.74	11.89	1.94	1.42	1.94	2.07	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	37.37	16.74	1.94	3.15	1.21	1.21	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	36.12	14.71	0.00	2.84	2.06	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.98	12.98	1.58	2.53	0.95	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	37.91	14.29	1.65	1.65	2.75	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	36.54	19.80	1.65	2.36	1.89	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.47	11.63	1.29	1.29	2.26	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	38.18	10.32	0.72	1.81	1.99	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.40	12.56	0.63	3.14	2.30	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	34.19	13.48	0.78	2.15	1.17	1.17	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	39.25	11.40	0.42	2.32	3.17	1.48	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	52.12	18.47	0.33	3.30	1.65	2.14	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	40.02	14.77	0.56	2.62	2.06	1.31	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	32.77	10.16	0.57	2.11	1.53	0.96	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	36.38	13.69	0.61	1.84	2.25	1.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	31.23	12.49	0.40	1.81	0.81	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	38.62	13.24	0.00	1.89	1.62	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	40.33	11.04	1.20	0.96	1.44	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	29.17	12.23	0.71	2.12	1.65	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	45.53	15.08	0.29	2.64	1.17	1.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	32.69	10.33	1.27	0.84	1.05	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.64	11.19	0.87	1.05	1.92	1.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.12	9.44	0.80	1.61	1.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.38	12.10	1.16	1.86	2.33	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.19	8.64	0.24	1.44	0.00	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	34.87	14.60	0.60	2.68	1.79	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	29.68	14.36	0.24	1.44	1.91	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	32.55	14.36	0.40	2.22	1.42	1.21	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.10	13.32	0.82	3.07	2.46	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.58	11.56	1.33	1.56	1.11	1.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	69.96	0.00	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.36	9.58	0.71	1.06	1.77	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.19	12.26	0.66	0.99	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	112.42	48.66	0.00	5.03	4.19	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	43.63	22.96	0.46	3.67	3.21	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	24.63	9.40	0.65	3.89	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	22.48	8.67	0.96	3.53	0.96	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	49.66	18.86	0.00	7.23	3.77	1.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	7.76	0.00	1.41	0.00	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.99	5.61	1.12	0.56	1.12	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	83.59	26.27	0.00	0.80	3.18	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	40.77	11.21	0.00	1.36	1.70	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	17.22	4.87	0.65	2.27	0.97	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.17	8.52	1.77	1.77	1.77	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	63.18	0.00	0.00	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.70	4.88	1.46	0.98	1.95	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.83	6.45	2.98	1.98	0.99	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	18.76	9.85	0.94	0.94	0.94	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.86	5.96	1.99	0.66	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	16.70	8.04	0.62	1.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.90	5.50	1.83	1.22	0.61	0.31	0.31
Adipocyte - breast, donor1	11376-118A8	7.92	8.39	0.95	0.32	0.16	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	7.54	7.86	2.25	0.96	0.32	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	8.52	8.40	1.91	0.89	0.51	0.13	0.13
Adipocyte - omental, donor2	11474-119C7	8.97	6.73	1.49	2.24	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	9.71	2.01	1.67	1.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	14.67	7.66	1.91	1.28	2.55	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	4.40	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	24.84	14.45	1.35	2.71	1.35	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	22.07	13.03	1.74	0.52	0.35	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.04	6.26	4.89	0.59	0.98	0.39	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	12.87	4.12	3.09	0.00	1.03	1.03	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	15.05	5.58	5.02	0.28	0.84	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	6.47	4.11	4.70	0.00	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	9.65	5.55	2.98	0.40	0.88	0.48	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	13.88	5.81	2.58	0.97	0.97	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	11.73	5.87	1.60	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	7.79	3.34	2.78	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	7.90	5.82	0.83	0.00	0.42	1.66	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	10.30	6.28	2.51	1.26	0.75	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	9.16	3.93	0.65	0.98	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	3.65	3.35	2.13	0.61	0.30	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	53.48	26.08	2.43	4.86	5.30	2.21	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	56.66	39.09	5.02	3.23	0.36	1.08	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	16.77	9.58	2.40	1.20	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.03	12.23	3.60	1.44	0.54	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	8.37	3.35	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.68	9.25	3.49	0.62	0.62	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	18.99	10.87	2.06	2.06	1.03	0.46	0.11
Anulus Pulposus Cell, donor2	11463-119B5	13.22	5.88	2.20	1.22	1.71	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.52	7.19	1.35	1.80	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	8.68	0.87	0.43	1.30	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	8.56	0.00	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.55	7.47	2.09	0.60	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	11.38	1.26	0.00	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	4.62	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	14.29	4.55	3.90	0.32	1.30	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	5.34	0.00	1.46	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	15.44	10.69	2.38	0.59	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.56	10.17	2.64	1.13	0.75	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	14.51	5.08	3.63	2.18	2.18	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	7.52	2.51	0.00	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.34	8.57	2.64	0.82	0.16	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	10.92	1.36	1.36	2.73	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.12	9.65	1.51	0.90	1.06	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.22	9.64	1.61	0.00	0.00	0.54	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.17	7.18	0.57	0.38	0.57	0.19	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.29	7.75	1.60	1.07	0.53	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	2.93	2.93	0.00	0.00	0.98	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.94	8.13	1.82	0.66	0.66	0.83	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	7.20	1.20	0.00	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.46	5.15	2.06	1.20	0.69	0.51	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	12.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	6.80	2.43	0.49	1.46	1.46	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.11	9.11	2.28	0.76	0.38	0.38	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	10.90	0.00	1.21	1.21	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	5.70	2.28	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.34	5.77	2.14	0.43	0.86	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.90	8.52	1.55	1.03	1.29	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	5.63	3.75	1.41	0.94	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.93	6.43	2.89	1.29	0.96	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.13	5.71	1.43	0.71	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	7.02	3.51	1.17	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.24	5.12	3.31	0.30	0.90	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	8.32	2.38	1.19	3.56	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	11.70	3.56	1.53	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	19.10	6.62	2.04	0.76	1.78	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	10.80	3.18	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.08	7.77	1.29	0.43	0.86	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	15.45	6.77	2.33	0.42	1.06	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.99	2.90	2.61	1.45	0.58	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	3.78	1.89	0.00	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.90	6.10	2.37	0.17	0.68	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	9.27	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	8.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	15.44	5.79	2.36	0.43	0.86	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	8.42	4.21	1.80	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	5.10	2.92	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.56	7.13	2.07	0.69	0.92	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	5.10	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.47	10.17	1.02	1.27	0.51	1.53	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.56	7.43	3.30	0.41	0.62	0.83	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.04	6.12	1.53	0.31	0.00	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.69	6.69	1.91	1.43	1.91	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	12.64	6.87	1.77	0.44	0.44	1.11	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	7.63	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	15.51	9.42	2.77	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.97	7.15	2.12	0.26	0.79	0.26	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.36	8.00	1.09	0.73	0.73	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	43.11	25.30	3.81	3.19	2.46	3.19	1.47
Astrocyte - cerebellum, donor2	11580-120F5	35.43	25.16	2.40	1.20	1.71	2.40	1.03
Astrocyte - cerebellum, donor3	11661-122F5	20.35	16.57	1.05	1.26	1.26	1.47	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	30.68	20.92	4.53	2.79	1.05	1.39	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	32.68	16.50	5.34	3.07	1.13	1.62	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	35.35	21.18	4.33	2.83	1.94	0.89	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	56.31	25.80	3.21	3.21	1.72	1.95	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	50.74	22.80	1.50	3.76	1.88	1.75	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	49.16	20.48	2.50	3.07	1.93	1.93	0.00
Basophils, donor1	12241-129G9	2.88	3.66	1.83	0.26	0.52	0.26	0.00
Basophils, donor2	12242-129H1	7.58	6.86	1.08	1.08	0.36	0.00	0.00
Basophils, donor3	12243-129H2	3.38	3.09	1.18	0.29	0.00	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	17.90	11.64	2.80	1.29	0.86	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	23.77	18.29	6.86	2.74	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	41.43	23.85	3.77	1.88	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	27.45	20.59	2.70	1.46	0.83	0.83	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	12.21	9.21	1.84	0.69	0.00	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	17.81	12.78	1.26	1.44	0.54	0.36	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	39.16	16.28	3.50	1.03	3.81	4.23	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	46.81	28.65	6.06	2.33	3.03	4.89	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.78	19.19	5.76	0.64	3.20	2.88	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	31.03	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	2.82	0.56	3.38	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	1.30	0.93	1.67	0.37	0.00	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	1.76	0.66	1.76	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.38	2.83	5.09	0.28	0.00	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	3.79	3.03	5.31	0.38	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	7.89	2.63	5.26	0.66	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	2.17	0.29	0.58	0.00	0.00	0.14	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.60	0.30	0.60	0.30	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.08	0.00	0.24	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.00	0.33	0.33	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	1.10	0.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.50	0.50	0.50	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.59	0.00	0.00	0.20	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.07	0.36	0.36	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	2.18	1.74	0.00	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	1.17	0.23	0.00	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.58	1.06	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	1.11	0.00	0.00	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.19	0.74	0.15	0.15	0.00	0.15	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.20	0.40	0.20	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.50	2.29	0.21	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.29	0.69	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.90	1.13	0.45	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.87	1.31	0.44	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	1.08	0.27	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	1.57	0.87	0.35	0.00	0.00	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	1.68	1.26	0.00	0.00	0.00	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.73	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	1.06	0.35	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.44	0.00	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.74	0.35	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.23	0.74	0.00	0.37	0.37	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.80	1.72	0.22	0.22	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1.64	0.82	1.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1.16	0.46	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1.86	0.70	0.46	0.00	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	12.86	5.23	0.87	0.22	0.87	0.22	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	9.01	1.39	2.08	0.46	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	14.73	6.72	3.68	1.52	0.43	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	7.63	4.05	2.34	0.93	0.47	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	4.37	1.92	2.97	0.00	0.00	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	6.69	3.57	1.56	0.67	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	13.01	5.87	1.79	1.79	0.77	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	6.81	3.51	3.07	0.44	0.22	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	13.69	5.26	2.32	0.42	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	22.36	2.03	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	14.24	7.46	0.00	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	10.36	6.21	1.04	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	24.52	15.99	8.00	1.07	1.60	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	20.37	14.47	8.58	0.54	0.54	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	13.34	9.83	6.32	0.70	0.00	2.11	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	18.82	11.77	3.14	1.57	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	22.41	13.18	9.23	3.95	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	4.93	4.11	1.64	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	7.25	4.35	2.18	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	5.05	2.52	2.52	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	40.00	23.84	8.89	2.02	2.02	4.04	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	38.35	17.58	6.79	2.80	3.60	2.00	0.40
CD34+ Progenitors, donor1	11545-120B6	7.03	6.02	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	6.74	3.93	0.56	0.56	0.00	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.44	12.78	7.89	1.88	3.38	3.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	39.46	20.07	5.64	2.25	3.61	3.61	0.45
CD4+ T Cells, donor1	11225-116C1	3.93	6.78	3.21	0.36	0.00	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	6.12	3.67	5.51	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	2.74	3.96	6.10	0.30	0.30	0.00	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	21.70	20.93	6.38	2.55	1.53	2.04	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	15.27	18.19	5.17	2.25	1.57	1.12	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	9.49	17.82	4.31	3.16	1.44	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	13.75	20.86	8.53	0.47	0.95	1.42	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	11.24	19.67	5.62	1.40	0.70	0.00	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	16.48	6.59	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	17.63	18.64	1.73	3.03	1.16	0.87	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.91	15.08	4.24	1.86	1.53	1.02	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.74	17.25	2.26	1.93	0.64	0.97	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.97	11.66	7.62	0.45	0.45	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	12.93	20.26	4.19	2.10	0.70	0.35	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	11.00	10.56	2.64	2.64	1.76	1.32	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.13	18.55	2.95	1.69	1.26	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.92	18.28	2.49	2.29	0.62	0.83	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.37	22.05	2.00	2.00	0.67	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	9.52	17.68	5.71	1.09	1.09	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	8.04	20.37	6.97	1.07	0.54	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	8.97	3.59	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	25.77	19.66	5.38	2.23	1.85	1.30	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	15.38	17.76	4.55	2.17	0.87	1.73	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	13.87	15.97	3.78	2.94	0.63	1.26	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	13.65	16.68	6.07	0.00	0.00	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	10.40	15.16	8.67	0.87	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	13.51	17.00	4.79	2.18	1.74	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	21.28	20.78	12.87	1.48	0.99	0.49	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	20.31	18.46	15.69	3.69	1.85	1.85	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	22.33	19.54	15.35	1.40	1.40	4.19	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	22.43	17.17	13.29	1.94	0.55	1.38	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	21.10	22.58	13.50	4.42	1.47	2.21	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	13.86	16.94	9.24	1.54	0.00	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	16.12	23.64	9.31	1.79	0.36	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	20.77	19.39	13.85	0.00	2.77	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	6.55	7.20	7.86	0.00	0.33	0.00	0.98
CD8+ T Cells, donor2	11307-117C2	6.38	4.88	3.75	0.00	0.00	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	7.07	5.55	4.04	0.50	0.25	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.26	24.77	1.61	5.28	4.59	2.98	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	37.86	23.72	2.64	1.68	2.88	2.40	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	37.76	19.97	3.01	2.46	2.46	2.46	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	58.54	32.72	1.80	4.80	3.00	5.70	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	41.04	26.40	2.88	2.88	3.12	2.40	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	39.57	27.74	2.96	2.50	2.96	2.05	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	50.84	26.94	3.69	4.13	3.26	1.96	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	43.43	26.58	4.21	2.11	2.63	2.63	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	39.16	21.81	3.75	3.99	2.81	3.05	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	54.64	31.70	2.42	2.72	2.42	3.92	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	38.93	25.56	1.74	4.07	3.20	3.20	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	48.49	31.71	1.87	2.13	2.93	2.93	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.57	11.82	0.88	0.44	0.88	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	20.49	16.40	1.82	3.19	1.37	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	18.65	12.68	0.75	1.49	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	40.70	28.45	3.24	4.32	1.08	2.88	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	35.10	22.73	4.32	1.44	2.01	3.16	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	34.65	22.16	4.01	2.59	1.65	1.41	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	52.61	32.32	3.49	3.17	0.95	2.54	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	50.13	32.29	5.54	1.85	3.08	1.85	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	35.26	31.42	2.56	1.92	2.24	1.92	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	47.04	30.21	1.53	1.91	3.06	1.91	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.14	27.59	4.34	0.79	1.18	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.99	19.67	3.03	2.27	1.51	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	34.53	21.68	5.62	0.00	2.41	3.21	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	31.47	13.99	3.50	2.10	0.00	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	32.06	21.04	2.00	2.00	0.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	5.48	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	21.25	9.39	1.48	0.99	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	20.31	12.63	1.79	2.00	1.89	1.79	0.32
Chondrocyte - de diff, donor1	11261-116G1	12.48	10.40	4.16	2.08	1.04	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	15.64	11.37	2.13	1.07	2.13	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	15.82	7.85	3.75	0.46	1.02	0.46	0.46
Chondrocyte - re diff, donor2	11339-117F7	36.71	21.49	1.79	5.37	0.90	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.50	11.73	4.85	1.62	3.24	1.62	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	23.53	18.94	2.75	1.84	0.92	0.69	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	16.03	17.10	2.99	0.86	0.43	1.07	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	20.53	14.43	3.63	1.33	0.97	0.44	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	9.63	15.31	7.79	1.65	0.46	0.55	2.48
Corneal Epithelial Cells, donor1	11526-119I5	21.74	20.86	4.17	0.88	0.88	0.66	0.66
Corneal Epithelial Cells, donor2	11606-120I4	22.75	18.20	1.14	2.28	1.14	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	39.11	25.82	4.86	2.56	1.28	0.51	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	7.43	6.60	1.16	0.99	0.33	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	6.94	5.68	0.95	0.63	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	3.45	0.00	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.18	4.32	2.59	0.22	0.32	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	4.44	13.67	1.71	0.68	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	14.36	0.65	0.65	0.00	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	10.65	23.23	0.97	1.45	0.00	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	15.84	12.17	1.83	1.00	0.00	0.50	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	16.43	7.63	1.17	0.59	0.00	1.17	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	15.55	7.64	5.09	0.85	0.57	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	9.44	5.50	2.36	0.00	0.39	0.39	0.79
Endothelial Cells - Artery, donor1	11264-116G4	15.71	8.14	6.40	0.87	0.29	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	18.82	13.18	5.41	3.29	0.00	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	26.12	13.50	4.03	1.05	1.40	0.70	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	8.20	3.77	6.43	0.22	0.44	0.00	1.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	5.48	4.56	3.65	0.61	0.30	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	10.43	6.20	6.48	0.28	0.85	0.28	1.41
Endothelial Cells - Microvascular, donor1	11265-116G5	14.26	8.32	3.57	2.08	0.00	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	23.95	15.62	1.56	2.08	0.52	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	4.96	2.84	4.96	0.28	0.00	0.00	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	25.61	9.60	6.40	2.00	1.20	1.60	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.34	8.91	4.72	0.52	0.52	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	26.59	19.26	5.47	3.11	0.62	1.24	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	13.69	10.86	3.48	0.43	0.00	0.00	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.83	8.79	3.54	1.59	0.61	0.61	0.49
Endothelial Cells - Vein, donor1	11267-116G7	25.03	4.55	3.41	0.00	1.14	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	17.46	11.87	6.29	1.40	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	21.82	10.36	5.18	0.79	1.26	1.26	0.94
Eosinophils, donor1	12244-129H3	30.49	0.00	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	4.95	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	29.56	16.37	3.42	3.18	0.98	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	12.48	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.62	6.16	1.64	0.00	0.00	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.40	11.06	0.77	0.88	0.77	0.44	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.63	12.89	2.06	0.54	1.08	1.30	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.38	10.79	2.79	1.21	1.09	0.73	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.42	8.32	10.92	0.41	0.68	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.50	6.12	1.69	0.53	0.84	0.21	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	7.90	3.69	11.59	0.26	0.26	0.00	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.27	10.96	2.66	1.33	0.33	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	24.50	9.53	3.63	0.91	2.27	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	15.92	9.85	0.76	0.76	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	15.14	8.36	5.84	1.10	0.95	1.10	0.16
Fibroblast - Cardiac, donor4	11452-119A3	9.40	6.97	4.55	0.91	0.30	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	16.50	10.41	4.31	1.90	0.25	0.13	0.51
Fibroblast - Cardiac, donor6	11460-119B2	18.19	9.25	3.64	1.82	1.21	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.24	14.87	1.74	1.88	1.47	0.54	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.12	9.06	2.59	2.16	0.43	0.00	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	10.25	2.93	1.46	2.93	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	34.60	14.30	1.85	1.38	1.15	0.46	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	12.21	5.77	4.24	0.51	0.68	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	19.25	8.69	2.35	0.70	0.70	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	41.04	15.09	2.36	2.83	2.36	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	18.01	10.52	4.11	0.85	0.36	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	31.09	16.28	2.03	2.15	1.24	0.57	0.23
Fibroblast - Dermal, donor5	11454-119A5	37.33	17.27	3.31	2.79	2.27	0.87	0.35
Fibroblast - Dermal, donor6	11458-119A9	38.01	22.25	3.90	3.25	0.97	1.46	0.49
Fibroblast - Gingival, donor1	11237-116D4	18.53	10.83	2.08	1.87	0.00	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	10.48	6.29	1.31	0.79	1.05	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	29.12	12.78	3.29	1.71	0.79	1.05	0.40
Fibroblast - Gingival, donor3	11394-118C8	15.66	6.57	4.16	0.68	0.39	0.10	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	4.16	1.04	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	7.05	3.52	2.29	0.35	0.18	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.46	7.95	2.96	2.18	0.78	0.94	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.55	5.68	2.70	1.35	0.68	0.95	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	3.18	3.53	3.88	0.00	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.19	7.46	2.49	0.88	0.58	1.02	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.09	9.82	0.95	0.95	1.09	0.82	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.44	9.65	1.32	1.43	0.66	1.10	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	7.19	4.70	2.93	0.88	0.29	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	19.03	5.44	5.44	2.72	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	8.95	1.49	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	29.97	12.45	5.06	1.27	1.06	0.84	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	43.32	17.49	2.50	2.50	0.83	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	19.58	9.79	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	13.99	6.16	1.68	1.12	0.56	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	45.47	19.89	3.25	2.84	1.22	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	31.95	19.97	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	5.96	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.01	17.26	3.49	2.33	0.97	1.55	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	23.81	10.16	4.40	1.21	0.91	0.46	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	17.44	7.96	2.45	2.14	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.54	3.05	2.67	0.38	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.72	4.86	1.89	0.81	0.81	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	7.89	3.25	2.55	0.58	0.12	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	27.08	16.36	2.87	1.88	1.44	1.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	20.52	12.60	3.25	1.02	0.41	1.22	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	10.69	3.34	1.34	2.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.79	9.09	2.37	0.79	1.58	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.12	4.96	7.54	1.19	0.20	0.60	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.87	9.95	3.20	0.18	0.71	0.36	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.38	11.83	2.76	1.38	2.17	1.38	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	9.03	6.92	7.82	1.81	0.90	0.00	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.35	8.64	2.91	1.19	1.30	0.54	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.12	4.56	10.12	0.76	1.01	0.51	1.52
Fibroblast - skin normal, donor1	11553-120C5	12.14	6.73	3.94	0.16	0.33	0.49	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	9.62	7.82	7.82	0.20	0.40	0.40	0.40
Fibroblast - skin normal, donor2	11561-120D4	15.97	9.54	3.62	1.31	0.60	0.30	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	10.88	6.35	8.16	0.30	0.91	0.30	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.90	7.37	2.65	0.91	1.41	0.50	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.57	7.52	5.13	1.54	0.34	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	8.54	2.63	6.57	0.00	0.99	0.00	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.07	11.08	2.77	2.02	0.32	0.85	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	27.16	10.29	2.02	2.19	1.18	0.84	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	29.17	17.25	1.25	1.10	1.73	1.10	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	288.08	243.76	0.00	22.16	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	1.74	7.84	4.36	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.79	10.75	2.43	1.04	0.00	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	18.74	12.23	3.38	1.30	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.03	9.45	2.81	1.02	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	51.29	3.83	3.83	2.30	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	54.87	49.13	3.19	2.55	5.10	2.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	102.69	73.60	8.84	6.56	4.28	3.42	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	21.78	30.33	13.51	1.65	1.93	1.10	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	18.72	20.78	11.19	1.83	2.74	0.91	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	59.04	45.77	7.53	2.38	4.36	3.17	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	20.88	26.43	10.04	1.59	1.59	1.06	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	11.09	9.13	17.94	0.33	1.63	1.63	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	102.15	66.33	9.29	3.10	3.10	3.54	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	38.02	29.96	5.09	2.69	2.26	1.55	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	27.46	18.35	6.53	1.11	1.72	1.23	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.12	20.15	5.37	1.88	1.61	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	29.24	14.99	7.68	1.49	1.12	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	32.67	18.96	6.64	1.66	0.97	1.11	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	37.41	20.74	3.46	1.42	0.41	1.42	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	21.45	13.01	5.93	2.51	0.68	1.14	2.05
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	19.31	16.07	8.35	1.25	1.62	0.62	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	19.67	15.74	6.34	1.31	0.66	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	26.00	18.91	6.21	2.07	1.48	0.59	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.94	15.10	7.79	1.43	1.75	0.79	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	20.78	14.08	10.05	0.67	0.67	0.89	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	24.60	16.53	8.07	1.61	1.21	1.41	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	23.92	17.30	9.33	1.87	2.21	1.53	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	26.51	17.65	6.74	1.60	1.24	1.15	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	29.03	23.62	5.10	2.60	1.66	1.56	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.86	22.03	5.12	1.54	1.02	3.07	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	23.90	14.72	7.86	0.55	1.99	0.89	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.29	21.46	9.48	2.00	1.91	1.33	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	29.20	18.78	8.78	2.04	2.45	1.02	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.55	22.69	7.43	1.65	2.48	1.65	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	20.75	13.95	8.99	1.96	0.92	1.61	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	21.85	17.01	7.67	1.50	1.00	1.00	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	18.74	16.31	7.49	1.10	1.32	1.54	1.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	22.75	15.99	6.89	1.48	1.11	0.86	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	25.61	19.45	10.05	1.78	1.62	0.65	2.11
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	22.13	19.56	8.66	0.96	0.64	0.00	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.24	13.93	5.78	1.61	1.04	1.52	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.78	14.71	7.75	1.42	1.42	0.79	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	20.68	15.81	4.56	1.22	0.30	0.30	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.28	15.47	7.74	1.88	1.25	0.94	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	23.27	16.91	8.12	1.54	1.10	0.66	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.11	12.91	8.42	1.40	0.56	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.54	7.87	3.89	1.11	0.56	0.46	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.14	13.64	2.14	0.80	0.27	1.87	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	21.27	9.18	4.44	1.68	0.77	0.61	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.95	11.14	4.79	1.04	1.04	0.65	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.06	13.82	4.34	0.81	0.54	1.08	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.67	10.14	6.08	0.74	0.55	0.74	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	15.57	10.75	6.14	1.10	0.66	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	7.93	8.93	1.98	0.99	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	17.81	9.10	4.35	0.66	0.53	1.19	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.91	8.27	4.44	0.40	1.01	0.40	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	17.54	17.54	1.52	1.02	1.27	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	62.90	30.46	6.37	4.18	3.18	1.39	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	27.89	24.81	7.55	2.00	1.23	2.00	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	44.19	27.62	7.16	2.45	0.61	1.84	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	67.91	58.83	6.26	4.69	4.69	4.38	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	74.88	53.12	4.52	5.93	4.24	4.52	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.97	32.75	5.07	1.84	0.92	3.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	39.60	37.12	7.42	0.00	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	46.80	34.04	4.64	3.48	1.93	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	52.95	20.86	3.21	3.21	1.60	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	43.47	22.60	1.74	5.22	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	44.92	30.60	6.18	3.25	2.60	2.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	42.42	33.77	7.41	2.88	3.29	2.88	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	36.65	0.00	6.66	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.63	22.09	4.19	1.68	3.92	3.36	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	39.55	26.47	3.60	2.94	1.63	2.61	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	28.52	31.88	5.03	1.68	5.87	1.68	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	44.21	30.53	7.00	1.59	2.86	1.59	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	47.89	27.17	5.43	2.72	2.04	3.06	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	81.44	37.59	14.62	2.09	2.09	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	50.40	30.93	8.02	1.15	4.01	1.72	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	45.88	24.27	4.44	2.07	2.07	2.37	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	27.11	6.78	5.08	1.69	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	43.49	18.64	7.04	2.07	4.97	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	40.04	24.85	6.90	2.76	3.22	4.14	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	47.42	31.61	5.27	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.06	18.45	5.38	1.92	3.08	2.69	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	42.05	18.91	3.91	3.26	5.54	2.93	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	48.16	29.43	6.69	3.34	4.01	3.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	44.31	25.43	9.25	1.16	3.85	2.70	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.15	11.98	6.16	2.05	2.05	2.05	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	27.33	14.91	2.48	4.97	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	39.64	30.67	2.83	2.83	2.36	1.42	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	43.45	16.29	10.86	2.41	3.62	3.62	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	49.85	31.03	5.09	3.56	1.02	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	37.89	19.54	8.38	1.99	5.58	1.99	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	43.42	23.68	9.37	1.97	3.95	4.93	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	33.05	8.26	2.36	3.54	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	23.34	7.00	3.50	2.92	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.03	33.79	9.22	0.44	2.19	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	27.13	18.65	7.63	0.85	1.70	1.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	28.05	10.15	6.57	2.98	3.58	3.58	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	40.76	14.07	4.85	2.43	2.91	2.43	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	10.27	5.71	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	8.32	4.99	1.66	0.42	1.66	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	31.48	19.12	4.50	2.25	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	11.42	6.98	2.54	0.00	0.32	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.77	7.10	0.42	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	50.83	38.76	2.79	3.25	1.86	1.62	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	48.95	34.77	2.53	2.70	1.35	1.35	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	45.73	32.99	2.05	3.64	1.82	2.28	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	54.55	34.10	2.73	4.37	2.30	1.20	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	49.64	36.11	1.07	4.30	1.50	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	53.17	34.45	1.72	2.80	1.72	0.86	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.41	34.87	2.62	3.99	1.87	1.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	51.64	26.42	1.54	3.09	1.72	1.20	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	59.91	30.76	1.92	4.16	1.28	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.91	12.31	2.24	1.12	1.12	0.00	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.77	14.28	3.46	3.03	0.43	0.87	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	5.29	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	23.99	13.76	4.23	0.71	2.82	2.12	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	11.62	6.54	3.63	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.27	13.64	1.05	1.92	1.75	0.70	0.00
Hepatocyte, donor1	11523-119I2	15.74	4.84	3.63	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	31.24	10.77	3.23	2.15	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	15.95	12.27	7.98	0.61	1.84	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.25	21.54	1.31	1.31	5.22	8.48	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	27.97	12.93	7.52	1.75	1.22	1.92	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.30	16.05	1.37	1.37	1.92	2.33	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	105.07	28.66	12.74	0.00	6.37	6.37	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	33.38	20.03	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	63.68	30.46	12.46	4.15	2.77	4.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	70.07	25.03	10.01	2.50	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	23.74	11.87	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	12.81	25.63	5.13	5.13	15.38	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	68.56	13.71	4.57	4.57	9.14	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	40.61	19.49	4.87	4.87	8.12	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	70.03	41.68	11.67	6.67	3.33	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	58.09	21.78	7.26	3.63	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	74.11	34.41	22.50	2.65	11.91	6.62	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	69.84	26.61	6.65	1.11	9.98	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	26.19	15.71	0.00	5.24	15.71	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	71.80	28.34	11.97	3.15	3.15	5.04	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	51.04	32.48	4.64	3.09	9.28	10.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	64.60	25.20	13.57	1.29	5.17	5.81	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	72.45	27.37	3.22	4.83	3.22	8.05	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	35.84	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	67.63	23.63	10.59	2.44	2.44	3.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	69.27	40.72	7.56	1.68	5.04	7.98	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	43.12	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.88	26.52	5.63	0.80	4.02	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	54.47	27.70	8.31	2.77	2.77	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	45.24	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	52.87	22.19	6.14	1.89	4.72	5.19	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	60.77	14.51	4.53	5.44	5.44	9.98	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	59.19	32.28	8.61	1.08	2.15	6.46	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	76.23	27.95	5.08	2.54	2.54	6.35	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	68.87	23.59	12.75	1.91	7.01	3.19	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	63.79	38.28	20.05	1.82	3.65	12.76	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	65.69	24.99	12.14	2.86	4.28	5.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	92.91	29.86	9.95	0.00	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	50.93	20.99	11.11	2.47	4.32	5.56	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	68.48	28.10	14.05	0.00	7.02	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	69.15	34.57	15.72	6.29	3.14	9.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	52.85	22.95	15.99	4.17	4.87	4.87	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	79.67	28.77	8.85	6.64	11.07	8.85	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	16.21	3.24	0.00	6.48	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	68.01	27.03	17.44	2.62	0.00	2.62	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	76.49	24.75	9.00	6.75	6.75	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	59.24	34.85	17.42	3.48	3.48	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	71.47	23.47	10.67	1.07	7.47	4.27	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	65.12	31.87	18.01	1.39	2.77	4.16	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	79.79	48.44	11.40	0.00	8.55	8.55	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	50.62	24.85	13.81	0.00	3.68	3.68	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	72.61	18.15	21.18	3.03	6.05	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	6.21	12.42	0.00	0.00	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	44.41	13.75	10.57	2.11	3.17	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	10.44	9.96	2.61	0.57	0.33	0.33	0.24
Keratinocyte - epidermal, donor2	11349-117G8	17.57	5.86	1.76	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	25.27	16.19	4.45	1.70	0.66	0.57	0.28
Keratinocyte - oral, donor1	11251-116E9	25.77	21.11	3.86	2.72	0.45	0.34	0.23
Keratocytes, donor1	11527-119I6	25.10	19.25	4.81	2.41	1.72	0.34	0.69
Keratocytes, donor2	11607-120I5	48.04	18.75	2.34	2.34	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	16.20	8.10	1.98	1.19	0.40	0.59	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	4.40	13.19	4.40	0.00	2.20	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	20.50	17.26	5.39	2.16	1.08	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	18.57	12.69	3.69	1.50	1.04	0.92	0.23
Lens Epithelial Cells, donor3	11690-122I7	12.01	11.91	1.01	1.41	0.71	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.84	9.72	2.85	0.59	0.83	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.86	8.65	2.79	1.67	0.84	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	13.85	6.45	3.46	1.10	0.79	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	10.75	12.91	0.00	0.54	0.54	1.61	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.98	10.72	1.89	0.63	0.32	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.61	8.52	2.16	0.86	0.32	0.75	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	8.62	2.46	0.00	1.23	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.66	10.11	2.28	0.76	1.01	0.51	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	10.56	7.32	2.25	0.70	0.84	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	14.24	6.72	1.58	1.19	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	13.57	8.34	2.91	1.16	1.55	0.58	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	12.22	9.26	3.15	0.74	0.93	0.93	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.50	8.36	3.48	1.74	0.00	0.70	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	12.88	9.30	1.91	1.43	0.95	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	11.95	8.65	2.61	0.82	0.27	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.85	6.16	1.54	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	15.28	10.29	0.62	1.25	0.00	0.31	1.56
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.99	9.52	3.11	0.37	0.37	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.84	8.56	1.65	0.66	0.66	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.76	11.42	1.46	0.59	0.88	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	13.19	7.97	2.74	1.24	0.25	1.00	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.91	8.24	2.42	0.97	0.48	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.46	10.23	1.35	0.81	0.81	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.44	7.27	1.82	0.91	1.21	0.45	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.52	9.33	3.11	1.04	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	10.68	9.63	3.14	1.68	0.42	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.08	9.02	1.95	0.90	0.75	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	6.19	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.16	9.22	2.63	1.32	0.94	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.53	9.22	2.12	1.17	0.21	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.11	8.24	1.45	0.48	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.90	10.25	1.32	0.33	0.66	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	13.75	5.70	2.35	0.62	0.50	0.37	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	17.40	8.89	4.07	1.48	0.74	1.11	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.86	9.14	1.24	1.73	0.49	0.74	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.85	5.09	1.79	0.55	0.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	12.87	7.08	1.93	0.96	0.32	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	11.26	9.74	2.74	1.52	0.61	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	15.26	9.24	1.96	0.28	0.14	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	12.80	7.11	4.62	1.07	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.91	2.91	0.48	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.20	9.80	2.80	2.02	0.93	1.09	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.46	11.10	5.01	0.36	1.07	0.36	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.05	7.51	1.96	1.63	0.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	15.77	9.18	0.94	0.71	0.71	1.41	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	20.79	13.12	3.34	1.49	0.99	1.11	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.01	11.01	2.56	1.54	0.26	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.02	8.65	2.09	0.60	0.60	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	38.52	49.85	0.00	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	36.06	27.62	5.37	1.53	2.30	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	34.14	34.14	5.20	1.48	2.97	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	34.27	42.74	4.65	3.39	2.54	1.69	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.28	33.06	7.03	4.92	2.81	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	42.96	25.22	6.54	6.54	2.80	3.74	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	38.65	32.46	4.12	3.09	4.12	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	38.06	4.76	5.95	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	42.07	47.95	8.60	3.85	2.49	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.86	30.83	4.94	3.20	2.33	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	44.57	27.46	4.95	1.80	3.60	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	41.87	42.27	11.79	3.93	2.30	1.63	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	35.95	42.62	3.08	1.03	1.54	4.11	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	33.17	32.82	7.76	4.59	2.82	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	38.65	26.65	4.66	1.33	2.00	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	45.34	30.56	7.13	3.57	2.55	3.57	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	35.75	30.95	8.00	4.00	3.20	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	41.57	35.14	8.31	3.40	2.46	2.46	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	45.40	34.97	8.59	3.68	3.68	3.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	53.00	21.20	7.34	4.89	6.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	33.94	35.61	7.50	1.67	3.33	1.67	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	33.91	31.39	6.73	3.64	3.64	2.24	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	45.33	35.03	9.27	4.12	2.06	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.03	41.51	11.03	1.16	2.90	2.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	35.57	34.08	5.38	2.09	3.29	1.79	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	34.30	30.43	6.64	3.87	3.87	3.32	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	38.18	26.87	12.73	3.53	3.53	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	40.93	29.87	5.16	2.21	2.58	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	48.35	37.99	12.66	2.30	4.61	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	40.68	42.60	8.06	2.69	2.30	1.92	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.27	29.44	4.53	2.26	6.23	3.40	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	55.79	23.79	5.74	1.64	0.82	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	38.41	35.25	9.49	0.45	3.62	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.19	28.73	6.46	1.44	2.15	1.44	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	40.33	31.37	5.23	1.49	0.00	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.04	28.61	6.69	1.11	2.23	2.23	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.49	30.15	4.31	1.29	5.17	3.02	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	39.39	31.68	6.85	1.71	5.99	4.28	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	36.65	31.65	11.99	2.33	2.00	1.67	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	42.83	24.13	6.64	1.81	1.21	3.02	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	31.28	7.82	2.84	1.42	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	44.34	31.28	7.22	1.37	3.09	3.09	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	39.18	24.69	8.05	1.07	3.22	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	42.42	34.34	6.73	4.71	2.02	2.69	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	39.26	29.26	9.26	2.59	0.74	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	50.01	34.89	6.98	3.49	0.00	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	34.91	31.73	8.46	3.17	0.00	3.17	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	37.21	34.01	15.21	2.40	2.80	2.80	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	49.43	36.34	9.45	0.73	2.91	5.09	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	48.29	50.59	10.73	3.07	8.43	2.30	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	51.79	46.86	11.84	1.97	2.47	2.47	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	37.64	25.41	5.65	4.70	2.82	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	46.76	35.20	12.57	1.51	5.03	2.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	52.72	35.60	9.91	1.35	3.60	3.15	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	51.63	20.65	8.61	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	40.53	34.29	6.68	5.34	5.34	3.12	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	50.05	31.28	11.73	3.13	2.74	2.35	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	35.63	37.60	3.96	1.32	3.96	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	52.41	39.96	9.34	2.59	2.59	2.59	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	48.13	34.13	8.75	2.19	3.06	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	37.46	35.22	6.71	2.80	2.80	3.35	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	41.51	36.21	13.25	3.97	1.32	1.32	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	47.83	37.41	15.43	3.09	3.09	2.31	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	40.00	37.98	8.10	5.06	3.54	2.53	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	37.97	32.68	8.65	1.92	2.40	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	47.31	36.57	11.93	1.19	4.37	1.99	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	35.85	30.38	12.15	3.65	4.25	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	49.80	36.66	4.84	4.15	4.15	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	40.28	40.28	12.92	3.80	3.80	3.04	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	56.29	39.76	7.75	2.07	5.68	2.58	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	48.37	32.05	13.91	0.60	6.05	3.02	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	45.32	38.66	14.89	2.85	2.85	2.85	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	42.11	39.98	7.46	3.20	4.26	3.20	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	63.21	41.95	14.37	3.45	4.02	3.45	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	42.17	45.77	11.31	2.06	3.09	3.09	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.90	31.12	7.07	2.12	6.37	2.12	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	54.48	43.13	11.92	1.70	3.40	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	52.42	43.68	10.40	2.08	2.91	1.66	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	30.54	33.67	9.40	4.70	4.70	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	58.87	34.66	5.85	2.09	2.09	2.51	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	44.61	36.71	10.22	2.79	3.72	4.65	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	43.49	44.83	6.02	4.01	6.69	2.68	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	47.58	41.70	8.55	3.21	4.81	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	49.30	40.01	8.08	3.64	4.04	4.85	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	34.87	42.22	4.59	2.75	1.84	1.84	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	73.80	36.45	12.45	1.78	3.56	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	47.30	40.46	9.12	2.28	4.56	3.99	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	59.82	34.51	11.50	3.83	4.60	3.83	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	47.60	26.81	9.85	3.83	3.83	4.38	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	44.54	42.76	11.14	1.78	3.12	3.12	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	53.29	44.71	10.40	3.12	5.20	3.90	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	60.34	42.44	9.28	1.99	3.98	3.32	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	37.41	16.63	6.24	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	3.65	3.65	3.87	0.46	0.46	0.00	0.68
Macrophage - monocyte derived, donor2	11313-117C8	4.77	4.59	0.92	0.37	0.18	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	4.59	4.19	3.80	0.52	0.13	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	20.71	18.05	2.66	1.06	0.00	1.59	1.06
Mallassez-derived cells, donor2	11929-125I3	13.31	9.67	3.01	0.63	0.48	0.63	0.95
Mallassez-derived cells, donor3	11930-125I4	34.47	16.82	3.89	1.95	1.11	1.11	1.25
Mammary Epithelial Cell, donor1	11273-116H4	29.59	20.73	2.69	0.90	0.70	0.70	0.90
Mammary Epithelial Cell, donor2	11350-117G9	50.09	26.93	2.32	2.03	2.90	0.87	1.74
Mammary Epithelial Cell, donor3	11422-118F9	48.14	20.20	2.74	2.24	0.75	1.25	0.00
Mast cell - stimulated, donor1	11487-119E2	12.88	8.14	0.00	0.00	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	11.79	6.92	3.35	0.97	1.62	0.65	0.22
Mast cell, donor2	11565-120D8	6.84	5.94	10.40	0.59	0.30	0.30	0.30
Mast cell, donor3	11566-120D9	6.30	4.73	12.16	0.23	0.90	0.90	0.23
Mast cell, donor4	11567-120E1	5.32	3.55	12.06	0.18	0.35	0.35	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	14.19	7.54	2.22	1.00	1.00	0.78	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	7.59	4.09	2.92	0.58	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	11.36	6.88	3.67	0.80	1.61	1.15	0.34
Mast cell, expanded, donor8	11941-126A6	10.21	7.03	7.36	1.00	1.67	1.00	0.67
Melanocyte - dark, donor1	11502-119F8	22.09	12.14	4.58	1.49	0.40	0.40	0.60
Melanocyte - dark, donor2	11582-120F7	16.61	9.00	2.42	0.35	0.35	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	26.66	13.69	3.69	2.68	1.52	1.09	0.65
Melanocyte - light, donor1	11274-116H5	12.46	7.52	2.59	0.71	0.94	0.24	0.00
Melanocyte - light, donor2	11351-117H1	11.60	6.14	1.36	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.95	8.67	0.87	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	32.80	13.43	8.64	1.35	1.25	1.15	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	25.28	10.22	4.30	1.34	0.27	0.81	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	18.21	9.64	4.02	1.61	0.27	0.27	1.07
Meningeal Cells, donor1	11493-119E8	27.42	18.36	3.23	1.49	0.50	1.49	0.37
Meningeal Cells, donor2	11573-120E7	24.21	12.32	2.64	1.76	0.44	1.32	0.00
Meningeal Cells, donor3	11654-122E7	24.29	13.61	2.28	2.85	1.30	1.71	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.52	15.11	2.57	2.85	3.42	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.08	7.65	0.70	0.30	0.50	0.20	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	9.20	10.51	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	43.17	22.24	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	42.34	25.83	2.15	2.87	0.72	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.95	4.66	2.96	0.00	0.21	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	11.56	7.54	2.01	1.01	1.01	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	38.46	21.76	1.10	2.20	1.76	1.76	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.18	23.38	1.46	2.92	2.92	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.28	19.23	3.07	2.25	1.64	2.25	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.44	11.22	2.35	1.66	1.39	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	18.21	10.78	4.46	1.12	0.37	0.74	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	17.63	9.74	1.71	1.45	0.66	0.53	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	19.88	12.46	1.78	0.00	1.19	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	16.35	9.34	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.10	15.37	5.12	3.20	0.64	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	49.62	21.62	2.48	4.61	1.42	1.42	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	19.39	9.38	2.19	2.19	0.94	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.03	20.32	2.18	1.45	0.73	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	11.67	6.63	1.33	0.80	0.00	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	17.02	14.01	3.00	0.50	0.50	1.50	0.50
Mesothelial Cells, donor3	11402-118D7	7.30	4.99	1.81	0.51	0.79	0.14	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	1.35	4.05	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	4.43	3.45	2.46	0.99	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	5.30	2.65	1.18	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.20	4.03	2.17	0.62	0.62	0.00	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.02	2.90	0.62	0.21	0.41	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.51	4.00	1.75	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.26	2.33	0.47	0.00	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	3.45	3.66	1.83	0.61	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	5.15	3.56	0.79	1.19	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	4.42	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.46	6.08	1.14	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	4.24	2.33	0.21	0.21	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	2.76	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	3.28	1.49	0.30	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	1.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.26	3.01	0.50	0.25	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.09	1.66	1.66	0.48	0.00	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.55	0.55	0.00	0.00	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.07	2.99	0.69	0.92	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	1.68	3.79	0.63	0.63	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	2.85	3.26	0.61	0.61	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.72	1.72	0.21	0.86	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.89	1.78	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1.75	1.75	0.44	0.44	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.51	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	1.66	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	2.17	1.36	0.27	0.00	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.94	3.23	0.29	0.59	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	0.00	0.00	0.00	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	3.36	0.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	2.00	0.40	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	2.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	2.00	2.50	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.20	4.82	2.63	0.88	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	1.10	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	2.56	0.00	3.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	12.15	4.96	0.50	1.24	1.24	1.49	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.70	1.39	0.00	0.70	0.00	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	13.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	13.68	4.79	2.39	1.71	1.03	1.03	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.88	0.00	0.88	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.33	0.36	2.49	0.00	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.43	6.45	1.12	0.56	2.81	1.40	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	2.08	0.83	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	2.33	0.58	0.58	0.00	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	8.45	3.02	0.90	0.90	1.21	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2.92	2.09	0.42	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	1.85	1.85	0.92	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	3.41	1.14	2.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.84	1.66	0.69	0.41	0.14	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.55	3.89	1.81	0.52	0.26	0.78	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	2.57	2.14	1.72	0.00	0.86	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.64	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.07	1.87	0.53	0.00	0.27	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.09	2.69	0.90	0.30	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.23	1.70	1.27	0.14	0.28	0.14	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	6.69	3.82	1.59	0.64	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	3.98	3.10	1.55	0.44	0.00	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.52	1.14	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	6.53	3.41	1.42	0.57	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	4.42	3.69	1.97	0.74	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.23	0.88	1.76	0.59	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	3.46	2.31	0.86	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	3.30	4.53	0.82	0.41	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.08	2.38	0.30	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	7.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	3.56	1.78	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	7.23	2.96	2.63	0.00	0.33	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	2.10	2.10	0.00	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	3.36	2.37	1.58	0.40	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	4.66	2.79	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.13	1.50	3.38	0.00	0.38	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.46	2.40	1.07	0.53	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.99	3.17	1.24	0.23	0.45	0.23	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.16	1.47	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.13	2.20	6.60	1.10	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	1.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	5.88	2.14	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	2.02	2.02	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	4.22	2.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	1.36	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.18	3.81	1.27	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.81	1.62	0.81	0.81	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	3.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	5.71	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	3.26	3.26	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	15.08	9.05	2.80	0.86	0.86	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	6.79	2.61	2.61	0.52	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	4.67	0.00	0.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	9.60	4.17	1.67	0.00	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	40.69	22.82	1.33	2.09	1.52	3.42	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	4.79	0.00	0.00	1.60	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	4.08	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	64.32	38.59	1.84	5.51	0.00	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	7.53	0.42	0.42	0.42	1.26	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	9.30	6.28	1.63	0.23	0.23	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	10.81	5.13	0.27	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	5.47	3.78	1.68	0.21	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	22.27	0.00	33.40	0.00	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.89	6.45	0.50	1.49	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	14.62	8.93	0.54	1.35	0.27	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.20	5.21	0.91	0.00	0.45	0.68	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	9.31	2.45	1.31	0.49	0.49	0.65	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.94	4.56	0.91	0.18	0.00	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.08	9.55	2.65	0.53	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	5.40	0.60	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	42.66	21.00	0.98	1.64	3.94	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.16	3.25	1.46	0.33	0.00	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	7.76	5.64	1.41	0.53	0.35	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.95	4.92	1.41	0.00	1.41	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	10.57	1.84	0.00	1.38	0.00	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.25	8.68	0.32	0.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	41.39	21.38	0.00	3.10	0.69	1.03	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	70.80	55.63	5.06	0.00	5.06	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.69	4.01	1.34	0.45	0.22	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	5.50	1.27	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	10.92	6.65	0.71	0.47	0.95	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.89	9.01	1.72	2.15	0.86	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	108.33	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.66	8.33	1.33	0.33	0.33	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.66	3.61	0.00	0.45	0.90	0.90	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	7.54	0.79	1.19	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	4.64	0.93	0.93	0.00	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	11.73	1.89	0.76	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.50	5.54	0.65	0.33	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.97	4.36	1.31	0.44	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	4.07	0.45	0.90	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	6.17	0.00	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	6.65	1.33	0.00	0.00	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.40	9.42	1.98	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.04	3.45	0.77	0.77	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.96	15.12	3.33	1.51	1.51	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	7.74	4.20	1.99	0.66	0.88	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	7.45	7.45	1.36	0.68	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	35.77	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.68	8.54	2.44	0.00	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	7.55	1.57	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.92	9.68	1.21	1.51	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	6.33	0.79	0.00	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	48.75	22.67	0.00	1.13	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	50.58	0.00	5.06	10.12	0.00	0.00
Myoblast, donor1	11241-116D8	15.03	11.55	2.73	1.37	1.12	0.87	0.50
Myoblast, donor2	11322-117D8	13.62	9.59	2.49	0.96	0.77	0.19	0.38
Myoblast, donor3	11398-118D3	12.44	11.44	2.02	2.19	1.18	1.35	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	34.73	10.51	5.84	1.90	3.65	3.36	0.44
Natural Killer Cells, donor1	11230-116C6	4.31	4.00	5.23	0.00	0.00	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	3.32	4.82	2.71	1.21	0.00	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	4.97	7.18	4.79	0.18	0.37	0.55	0.55
Neural stem cells, donor1	11275-116H6	13.79	11.25	4.36	0.73	1.81	1.09	0.00
Neural stem cells, donor2	11352-117H2	5.78	7.70	1.93	1.93	0.00	1.93	1.93
Neurons, donor1	11494-119E9	19.34	30.72	6.83	5.69	2.28	2.28	0.00
Neurons, donor2	11574-120E8	21.58	25.10	4.62	1.76	1.98	1.32	0.22
Neurons, donor3	11655-122E8	21.38	21.38	1.64	1.64	5.76	1.64	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	2.78	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	14.72	10.69	2.37	0.95	0.59	0.71	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	15.95	6.84	2.28	1.95	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	18.45	7.62	3.81	1.40	1.00	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	7.85	5.51	1.93	0.14	1.10	0.41	0.69
Olfactory epithelial cells, donor2	11934-125I8	13.46	7.82	2.89	0.58	0.58	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	7.95	5.22	2.50	0.91	0.57	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	12.66	6.43	4.48	0.49	0.49	0.19	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	27.68	10.83	4.21	1.81	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	14.89	9.78	1.91	0.64	0.64	0.64	0.43
Osteoblast - differentiated, donor2	11353-117H3	14.86	10.29	1.14	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.86	6.21	1.86	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	19.93	16.61	2.54	1.76	1.37	1.95	0.20
Osteoblast, donor2	11354-117H4	24.58	10.53	0.70	0.70	1.40	2.81	2.11
Osteoblast, donor3	11426-118G4	20.08	12.62	1.96	0.71	1.42	0.71	0.89
Pancreatic stromal cells, donor1	11249-116E7	18.19	8.17	2.78	1.01	0.59	0.67	0.42
Pericytes, donor1	11491-119E6	18.47	18.25	2.00	1.22	0.89	0.89	0.78
Pericytes, donor2	11571-120E5	21.50	16.07	2.94	0.45	1.58	0.45	0.23
Pericytes, donor3	11652-122E5	25.63	11.19	2.44	1.63	2.85	2.44	0.00
Perineurial Cells, donor1	11499-119F5	24.30	13.56	2.71	1.58	1.24	1.47	0.34
Perineurial Cells, donor2	11579-120F4	21.07	9.85	2.94	1.84	0.64	0.92	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.42	1.91	5.74	0.96	0.64	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	4.65	1.96	2.20	0.00	0.49	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	4.14	2.85	3.88	0.26	0.39	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	13.15	26.55	8.13	1.67	1.20	0.48	1.43
Placental Epithelial Cells, donor2	11355-117H5	21.07	27.72	3.33	0.00	1.11	4.44	1.11
Placental Epithelial Cells, donor3	11427-118G5	13.15	6.87	7.46	0.59	0.00	0.39	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	13.29	10.13	1.58	0.00	0.63	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	9.00	7.32	0.38	0.56	0.19	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.44	4.70	3.26	0.39	0.26	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	9.01	7.66	1.58	0.45	1.35	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	8.10	9.38	0.75	0.85	0.75	0.21	0.21
Preadipocyte - omental, donor2	11329-117E6	8.29	12.22	0.87	0.00	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	10.31	10.17	2.01	0.57	0.86	0.57	0.29
Preadipocyte - perirenal, donor1	11469-119C2	9.84	13.78	3.94	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.35	13.21	2.15	0.92	1.54	0.92	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	28.33	16.11	2.83	2.66	2.12	1.77	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	21.29	16.01	2.89	1.19	0.68	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	23.94	12.76	3.35	1.58	0.84	1.21	0.47
Preadipocyte - visceral, donor2	11357-117H7	11.96	8.74	4.60	0.92	1.84	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	23.30	13.58	1.57	1.67	1.36	0.73	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	27.91	11.77	8.60	1.36	2.72	2.26	1.51
Prostate Epithelial Cells, donor2	11331-117E8	11.65	10.97	2.30	0.81	0.41	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	4.16	4.90	2.88	0.31	0.06	0.12	0.12
Prostate Stromal Cells, donor1	11254-116F3	16.63	11.28	1.48	1.03	1.14	1.14	0.80
Prostate Stromal Cells, donor2	11332-117E9	16.14	9.32	2.87	0.90	1.43	0.36	0.36
Prostate Stromal Cells, donor3	11405-118E1	7.61	4.07	2.82	0.94	0.42	0.83	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.91	23.36	3.65	2.55	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.94	20.79	3.05	1.46	0.42	0.55	0.21
Renal Epithelial Cells, donor1	11517-119H5	25.36	25.36	5.07	2.54	1.01	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	27.03	17.78	2.13	1.42	0.71	2.13	0.00
Renal Epithelial Cells, donor3	11678-122H4	18.84	19.06	2.96	1.59	0.95	0.85	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.11	16.34	6.13	1.36	0.68	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	23.45	16.85	3.10	2.02	0.94	0.27	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	21.76	14.21	2.44	1.55	1.33	0.89	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	13.97	9.32	1.33	1.33	0.00	0.67	0.67
Renal Mesangial Cells, donor1	11518-119H6	23.11	18.27	1.98	1.98	0.66	1.10	0.66
Renal Mesangial Cells, donor2	11598-120H5	21.32	21.32	1.25	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.87	11.65	2.77	0.55	1.11	0.55	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	51.00	27.38	5.91	3.49	2.42	1.07	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.46	19.40	3.80	2.11	0.42	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.01	16.39	2.70	1.74	0.77	1.16	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	23.85	22.56	3.63	3.89	1.30	1.30	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	23.88	16.20	1.99	1.14	0.85	0.57	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	30.87	23.67	2.06	0.00	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	12.55	6.77	1.76	0.75	0.75	0.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	10.42	6.68	8.69	1.07	0.53	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	9.83	9.83	2.68	1.79	2.68	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	31.37	20.91	1.10	1.65	0.55	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	12.76	8.70	2.32	1.74	1.74	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	24.57	9.88	5.33	1.95	1.43	1.56	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.28	8.84	3.87	0.50	1.09	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	25.65	16.84	5.13	2.45	1.00	1.23	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	37.21	17.86	4.96	2.36	1.24	0.62	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	22.49	12.00	5.24	0.47	1.28	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.27	11.56	6.70	0.46	1.85	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.30	6.98	3.97	1.78	0.68	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.88	11.50	3.48	1.21	1.06	1.66	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.79	12.36	6.27	2.15	1.61	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.38	9.32	4.02	1.58	0.72	1.58	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.75	9.98	3.54	1.93	1.18	0.86	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	28.99	15.27	4.20	1.99	1.33	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.93	5.74	1.72	1.15	1.53	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	14.44	9.97	4.19	1.68	0.56	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.62	11.09	3.95	1.13	2.25	0.38	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	16.59	6.77	3.05	1.06	1.73	0.93	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	17.33	10.42	3.11	0.78	0.97	0.39	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	22.72	9.93	4.20	2.10	0.38	0.38	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	18.90	8.01	2.67	1.07	0.96	0.85	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.86	7.57	2.24	0.84	1.40	1.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	20.34	11.11	6.15	2.56	0.34	0.51	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	16.23	7.48	3.83	1.09	0.18	0.36	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.54	8.58	3.80	0.74	1.23	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	18.54	12.76	5.51	1.21	1.34	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	25.24	8.96	2.59	1.18	0.94	1.65	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	16.67	10.71	3.17	0.99	0.99	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	24.55	11.93	6.55	1.17	0.23	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	25.92	10.99	4.35	2.07	0.21	0.83	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.90	11.28	3.54	1.11	0.66	1.55	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	21.10	12.74	6.27	2.30	0.63	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	21.94	9.29	4.98	2.02	0.81	0.67	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	9.88	4.77	6.30	0.85	1.19	0.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.42	10.41	6.94	1.54	1.35	0.58	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	26.31	8.77	3.78	1.03	1.72	0.86	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	12.35	8.78	2.88	0.96	0.96	0.55	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	20.19	11.00	5.09	0.66	0.33	0.99	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	21.82	8.69	2.73	0.34	0.51	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	22.05	12.13	4.14	0.74	0.74	0.89	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.66	9.06	7.46	0.80	1.60	0.80	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	18.53	7.47	4.29	1.11	0.55	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.62	11.67	3.57	1.19	1.67	1.43	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.94	9.47	8.06	1.81	2.02	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.09	7.82	4.33	1.88	0.85	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.56	11.88	3.14	1.40	0.00	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	14.20	7.25	2.12	1.51	0.60	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	26.31	6.98	4.77	0.86	1.59	0.98	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	16.01	8.59	10.92	2.04	1.02	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.64	12.17	6.08	1.83	2.43	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	29.54	9.95	6.33	1.51	1.81	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	16.06	6.79	7.46	1.13	0.68	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	14.68	8.09	11.98	0.60	0.60	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.60	8.03	6.02	2.48	0.47	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.93	8.96	4.70	1.71	0.00	0.64	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	13.82	10.22	7.81	1.80	1.80	1.80	0.00
Schwann Cells, donor1	11498-119F4	25.95	23.51	3.20	1.88	0.38	1.50	1.13
Schwann Cells, donor2	11578-120F3	13.61	10.21	0.00	3.40	0.00	3.40	3.40
Schwann Cells, donor3	11659-122F3	13.80	10.95	1.75	2.41	0.22	0.44	0.00
Sebocyte, donor1	11220-116B5	19.72	11.50	3.29	2.74	0.55	0.00	1.10
Sebocyte, donor2	11301-117B5	12.41	9.65	3.22	0.92	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	14.43	13.81	2.89	1.24	0.62	0.41	0.41
Sertoli Cells, donor1	11255-116F4	18.22	8.28	4.97	1.66	3.31	0.00	0.00
Sertoli Cells, donor2	11333-117F1	33.89	0.00	2.82	2.82	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	14.08	6.42	4.49	0.70	0.18	0.44	0.88
Skeletal Muscle Cells, donor2	11358-117H8	14.46	4.34	5.78	2.17	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.93	19.23	9.20	1.67	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	46.66	26.23	3.77	2.83	0.79	1.41	0.47
Skeletal Muscle Cells, donor5	11455-119A6	41.03	22.89	2.53	3.72	1.78	0.59	0.45
Skeletal Muscle Cells, donor6	11459-119B1	49.71	32.63	3.69	5.23	1.69	0.92	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	28.86	16.76	2.27	0.50	1.01	1.01	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	19.83	12.98	4.28	0.86	0.86	0.71	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	35.81	21.23	2.78	3.08	0.99	0.89	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.02	10.87	2.02	0.93	1.52	0.51	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	6.51	0.72	0.72	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.27	8.81	2.89	0.69	0.69	0.96	0.69
Skin - palm, donor1	10286-104F7	0.00	0.00	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.83	10.67	2.59	0.58	0.72	0.72	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	14.72	13.09	8.18	0.00	0.82	0.00	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	16.23	15.19	1.17	1.69	1.30	0.91	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	10.01	10.15	1.81	0.70	0.83	0.28	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	6.47	4.08	2.39	0.70	0.00	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	11.42	9.73	26.22	0.21	1.06	0.21	2.75
Small Airway Epithelial Cells, donor3	11406-118E2	3.97	2.47	2.40	0.37	0.15	0.15	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	35.18	6.17	2.78	1.85	2.47	3.09	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	8.89	5.11	6.67	0.44	0.44	0.89	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	23.51	7.05	1.18	1.18	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	13.26	8.18	2.21	1.55	0.44	0.88	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	19.30	13.39	1.18	1.18	0.79	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	7.73	2.32	0.00	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	9.01	5.00	1.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.43	10.65	2.13	1.73	0.53	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.85	9.75	2.22	1.77	1.55	1.33	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	26.12	15.24	1.15	1.41	1.02	1.15	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.05	8.47	3.58	1.95	0.65	1.30	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.77	11.81	1.48	1.48	0.59	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.25	6.55	2.85	1.14	0.43	0.71	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.96	17.24	2.44	2.60	0.98	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	10.05	2.13	2.44	0.91	0.30	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.44	7.83	1.26	1.01	0.25	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	18.36	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	31.47	11.44	2.86	0.95	2.38	0.48	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.07	9.44	2.21	1.03	1.03	0.88	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.94	7.10	1.29	1.51	0.65	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	18.47	9.34	2.73	1.36	0.94	0.73	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.94	14.54	2.17	1.08	1.08	0.93	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	23.71	17.25	1.08	2.16	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	20.32	11.66	2.39	0.30	1.20	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	36.53	19.80	2.39	3.41	2.73	2.39	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	18.22	6.75	3.46	0.63	1.65	0.86	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.88	10.06	1.21	0.60	0.70	1.11	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	12.52	6.83	5.23	0.46	0.91	0.68	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	29.59	12.08	3.62	2.42	2.42	1.21	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	54.04	29.14	5.03	5.30	1.59	2.65	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.11	9.72	3.06	1.86	0.80	0.40	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	10.39	6.14	1.25	1.13	0.63	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	8.62	2.79	0.76	0.51	0.25	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.66	11.16	2.26	0.60	0.45	1.06	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	9.00	1.50	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	10.34	3.88	2.58	0.00	2.58	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.04	16.74	0.93	1.40	0.00	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.67	15.65	1.01	1.01	2.02	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	16.92	8.78	0.94	1.25	1.25	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.65	9.44	0.88	1.47	2.06	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	23.49	15.74	1.83	2.50	1.25	0.83	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	12.61	6.07	3.27	0.93	1.87	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.01	11.95	1.30	0.58	1.73	0.86	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.32	13.26	3.06	0.76	2.29	0.76	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.71	11.09	1.69	1.69	1.69	1.50	0.75
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	21.38	15.65	3.07	2.24	1.12	1.40	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	14.50	11.06	2.18	1.26	0.59	0.25	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	23.81	13.33	2.86	1.90	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.77	14.92	1.96	1.22	0.49	1.22	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.21	11.93	3.76	0.44	0.66	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.33	8.48	2.05	1.76	1.17	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.05	5.44	2.33	0.19	0.58	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.75	9.78	0.79	0.53	0.53	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.76	10.41	0.74	0.74	1.49	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.62	8.26	3.23	0.36	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.80	6.81	1.14	0.57	0.57	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	15.36	7.88	1.58	0.79	1.97	0.39	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	15.49	7.36	2.79	0.76	2.03	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	6.79	3.59	0.00	0.80	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	7.94	2.93	0.84	0.42	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	13.29	11.00	1.38	1.83	1.83	1.38	0.46
Synoviocyte, donor1	11291-117A4	13.80	6.73	1.35	1.18	1.01	0.50	0.00
Synoviocyte, donor2	11368-117I9	10.39	4.86	2.18	0.67	0.67	0.17	0.50
Synoviocyte, donor3	11440-118H9	9.83	4.47	3.35	1.34	0.45	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	46.81	26.80	3.57	1.07	2.50	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	29.73	13.87	0.00	0.00	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	24.08	15.28	3.24	1.85	0.93	1.16	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	17.92	13.40	2.01	1.36	0.57	0.29	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	25.51	24.35	5.41	2.32	2.32	2.32	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	21.76	11.45	5.73	2.29	0.57	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	10.33	7.01	6.77	0.37	0.86	0.25	0.00
Urethra, donor2	10319-105A4	7.19	0.00	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	22.05	15.14	3.45	2.39	0.53	1.33	0.00
Urothelial Cells, donor2	11600-120H7	15.62	10.41	2.00	1.60	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	12.15	10.09	4.58	1.38	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	15.60	8.47	6.02	1.56	0.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	7.12	9.79	12.46	0.00	0.00	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	7.15	8.58	7.15	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	4.11	4.79	4.11	0.00	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	6.54	6.54	6.89	0.34	0.69	0.34	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	4.07	6.39	6.97	0.00	0.00	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	2.08	6.25	3.12	1.04	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	6.42	9.18	5.51	0.92	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	2.74	2.74	0.00	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	25.91	22.82	5.55	1.85	1.48	1.23	1.36
Wilms' tumor cell line:HFWT	10597-108E3	5.28	4.40	3.52	0.00	0.00	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	47.48	26.26	7.82	1.96	0.56	0.28	3.07
achilles tendon, donor2	10292-104G4	8.27	8.27	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	91.02	52.52	4.84	7.14	3.31	4.59	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	51.54	23.91	6.27	1.39	4.88	6.97	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.71	34.19	3.32	3.68	2.14	1.90	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	71.57	58.78	1.90	6.26	4.08	3.81	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	68.87	33.45	3.37	2.53	3.65	5.62	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	42.72	28.76	1.90	3.60	2.33	2.11	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.49	14.97	4.90	1.91	1.63	4.63	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	44.06	13.22	10.58	2.64	4.85	2.20	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	43.69	15.52	7.76	2.04	2.86	5.31	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.48	13.98	6.60	1.94	3.11	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	53.36	34.96	2.39	3.86	2.39	2.39	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	23.40	23.40	0.00	3.90	7.80	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	34.62	17.89	5.58	3.25	3.49	3.49	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	69.90	29.51	9.06	6.47	3.88	4.40	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	43.84	23.09	5.84	2.05	2.63	3.80	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	22.31	9.30	5.11	1.39	4.65	2.32	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	24.26	6.99	3.70	1.23	3.29	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.51	4.91	0.31	0.61	1.23	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	30.72	12.37	4.27	1.28	2.56	4.27	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	28.21	13.34	3.03	1.21	3.34	1.52	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	31.05	16.37	4.09	2.17	3.85	3.85	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	41.87	22.72	4.23	2.67	1.11	2.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	34.69	24.68	3.67	3.34	2.00	2.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	18.58	5.57	0.00	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	28.25	16.57	2.64	1.51	0.75	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	32.27	9.16	1.31	1.31	4.36	1.74	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	13.12	3.75	0.00	3.75	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	47.57	15.78	8.48	1.65	0.94	1.18	0.00
adipose tissue, adult, pool1	10010-101C1	4.96	2.79	5.12	0.31	0.16	0.16	0.00
adipose, donor1	10184-103D4	29.91	48.67	5.28	1.76	2.35	2.93	2.35
adipose, donor2	10185-103D5	11.76	14.19	9.33	2.84	3.24	1.62	3.24
adipose, donor3	10186-103D6	17.43	13.61	9.80	0.82	1.36	1.09	1.63
adipose, donor4	10187-103D7	47.67	39.00	0.87	3.47	4.33	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	92.17	46.40	10.57	5.37	3.31	1.89	1.10
adrenal gland, adult, pool1	10081-102A9	7.28	0.00	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	34.15	22.41	5.87	3.07	1.73	1.07	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	32.51	11.43	7.50	1.07	1.07	1.43	1.07
amniotic membrane cells, donor1	12235-129G3	6.72	8.11	7.19	0.70	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	20.29	14.20	7.10	1.35	0.00	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	5.60	3.83	9.72	0.29	0.00	0.29	0.29
amygdala - adult, donor10196	10167-103B5	10.67	10.67	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	5.68	6.49	8.72	0.41	1.22	0.20	1.42
amygdala, newborn, donor10223	10360-105E9	5.16	8.71	4.84	1.29	1.29	1.29	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	15.28	8.66	4.20	1.02	1.02	0.89	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	128.18	41.26	6.40	4.85	3.75	2.87	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	39.42	8.35	9.02	1.34	2.00	2.00	1.34
aorta, adult, pool1	10052-101G7	5.88	5.10	7.85	0.59	0.00	0.20	0.78
appendix, adult	10189-103D9	9.70	7.76	8.15	0.78	0.39	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	61.22	22.36	5.16	2.75	4.82	2.41	0.34
artery, adult	10190-103E1	2.72	1.36	5.43	0.00	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	17.09	10.43	8.40	1.30	1.88	1.01	1.30
b cell line:RPMI1788	10427-106D4	68.55	29.00	2.97	2.68	4.16	3.72	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.76	12.76	1.94	1.94	0.55	1.39	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	54.68	25.50	1.98	2.68	1.39	1.19	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	29.63	9.71	1.34	0.50	0.67	0.84	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	22.37	6.71	2.80	0.00	0.56	2.80	0.00
bladder, adult, pool1	10011-101C2	8.15	4.13	5.32	0.11	0.65	0.11	0.33
blood, adult, pool1	10053-101G8	0.00	8.86	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	2.57	3.43	2.57	0.86	0.86	0.00	0.00
bone marrow, adult	10192-103E3	6.07	2.70	3.37	0.00	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	3.08	6.15	3.08	0.00	2.05	0.00	4.10
brain, adult, pool1	10012-101C3	6.68	10.24	3.12	1.00	0.45	0.00	0.89
brain, fetal, pool1	10085-102B4	5.34	8.01	5.34	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	22.46	18.17	7.27	0.99	1.65	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	40.32	22.09	10.73	1.62	1.62	2.25	1.62
breast, adult, donor1	10080-102A8	3.16	4.42	9.47	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	72.67	38.24	8.26	4.45	6.86	4.83	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	23.81	13.30	3.09	0.93	1.24	1.86	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	40.52	33.15	0.69	2.30	0.92	1.84	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	34.62	18.64	5.57	2.18	2.66	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	37.14	23.51	3.29	0.47	3.76	2.82	0.47
carcinoid cell line:NCI-H727	10735-110B6	12.47	8.75	2.73	0.66	0.44	0.44	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	52.92	31.69	4.12	1.90	2.22	1.27	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	35.67	22.36	7.99	4.79	1.06	2.13	1.06
caudate nucleus - adult, donor10196	10177-103C6	3.45	1.15	5.76	0.00	1.15	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	3.18	4.85	7.36	0.33	0.50	0.33	2.18
caudate nucleus, adult, donor10258	10379-105H1	4.58	16.05	2.29	0.76	0.00	0.00	1.53
caudate nucleus, newborn, donor10223	10354-105E3	6.23	7.69	5.86	0.73	1.46	1.10	0.73
cerebellum - adult, donor10196	10173-103C2	2.91	26.22	20.39	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	11.10	16.23	14.52	0.85	0.64	0.64	0.64
cerebellum, adult, pool1	10083-102B2	10.00	24.49	9.31	2.76	0.69	0.00	1.03
cerebellum, newborn, donor10223	10357-105E6	6.64	21.59	4.15	0.83	3.32	0.00	1.66
cerebral meninges, adult	10188-103D8	4.54	9.08	4.79	0.76	0.76	0.25	0.76
cerebrospinal fluid, donor2	10294-104G6	5.85	3.65	1.46	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	90.30	30.63	4.31	2.73	3.16	2.16	0.00
cervical cancer cell line:ME-180	10553-107I4	29.83	19.06	4.47	1.82	0.50	0.50	0.33
cervix, adult, pool1	10013-101C4	7.56	5.77	13.23	0.52	0.52	0.00	0.84
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.81	17.56	3.62	1.53	0.56	0.70	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	2.61	0.00	0.00	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	26.22	20.51	5.97	1.99	1.86	1.49	0.00
choriocarcinoma cell line:SCH	10785-110H2	33.02	15.52	2.83	1.72	1.72	1.72	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	47.20	28.94	2.85	0.71	1.66	1.19	0.00
chorionic membrane cells, donor1	12238-129G6	13.39	14.25	6.27	0.57	0.00	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	19.69	12.53	4.08	1.39	0.80	0.50	0.00
chorionic membrane cells, donor3	12240-129G8	19.78	19.23	3.30	0.00	2.75	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	56.55	29.28	2.02	2.02	9.09	8.08	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	34.00	12.87	2.69	1.54	3.27	3.65	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	21.96	11.83	2.53	0.42	2.75	3.38	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	42.89	22.08	4.37	0.26	3.60	4.88	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	42.57	15.48	6.77	2.18	4.35	6.77	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	40.93	16.49	3.66	2.44	4.68	3.46	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	40.34	13.54	2.36	2.36	4.42	4.71	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	38.83	19.03	2.61	0.52	2.35	3.65	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	49.83	19.66	3.20	1.83	2.51	1.14	0.23
clear cell carcinoma cell line:TEN	10636-108I6	39.91	15.10	1.21	1.91	2.78	1.04	0.17
colon carcinoma cell line:CACO-2	10513-107D9	38.44	15.38	4.21	1.83	3.29	4.03	0.18
colon carcinoma cell line:COLO-320	10420-106C6	96.54	53.21	6.08	6.08	2.66	3.04	0.38
colon, adult, donor1	10082-102B1	10.71	4.76	24.99	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	7.29	6.93	15.98	1.29	0.82	0.24	1.29
colon, fetal, donor1	10070-101I7	8.65	9.89	13.60	1.85	1.85	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	4.58	4.58	32.08	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	31.87	21.25	2.12	1.70	0.85	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	43.02	20.53	3.47	0.91	1.51	1.81	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	54.15	24.39	2.82	3.24	2.96	3.10	0.00
corpus callosum, adult, pool1	10042-101F6	3.76	7.52	7.96	0.22	0.55	0.22	1.22
cruciate ligament, donor2	10295-104G7	6.48	7.29	4.86	0.00	1.62	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	6.42	4.01	6.42	0.80	1.61	0.00	0.00
diencephalon, adult	10193-103E4	3.12	4.56	2.64	0.00	0.48	0.00	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	82.20	21.12	4.13	2.98	5.51	3.67	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	17.69	13.59	5.13	0.77	1.28	1.54	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	22.87	14.68	6.50	0.72	0.24	0.72	2.41
ductus deferens, adult	10196-103E7	2.99	4.49	9.47	0.50	0.00	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	7.20	10.08	21.60	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	10.30	14.71	16.92	1.47	0.74	0.00	1.47
dura mater, adult, donor1	10041-101F5	9.58	6.28	5.95	0.58	0.58	0.41	1.82
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	37.09	26.43	9.99	2.22	0.89	1.55	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.55	38.12	1.58	3.44	1.29	1.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	17.27	3.70	2.47	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.80	11.50	2.72	0.91	0.91	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	18.52	8.64	6.79	1.23	0.62	0.31	1.54
embryonic pancreas cell line:2C6	10603-108E9	15.76	3.94	3.94	1.31	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	17.09	22.79	4.02	0.67	1.01	0.67	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.25	15.77	6.16	0.72	0.00	0.72	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	29.91	38.43	3.54	2.57	0.32	0.48	0.48
epidermoid carcinoma cell line:A431	10426-106D3	34.79	23.90	4.56	1.11	1.45	0.67	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	56.97	23.76	7.92	1.76	3.63	3.74	1.32
epididymis, adult	10197-103E8	2.93	6.28	6.07	0.42	0.42	0.42	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	11.00	10.64	6.21	1.42	0.53	0.35	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.12	7.86	1.18	0.79	0.79	0.00	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	77.19	21.75	8.39	4.32	4.72	3.67	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	69.48	15.65	6.69	2.46	4.13	2.76	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	79.99	24.09	9.30	2.69	4.37	3.58	0.34
esophagus, adult, pool1	10015-101C6	7.54	7.86	7.75	1.17	0.21	0.00	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	12.02	13.28	7.14	1.50	1.00	0.38	0.88
eye - muscle inferior rectus, donor1	10272-104E2	0.00	2.41	2.41	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	4.21	4.21	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	2.98	0.00	2.98	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	4.59	2.29	2.29	2.29	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	1.46	1.46	8.74	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	8.64	7.88	5.59	0.51	3.05	0.25	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	75.40	38.98	6.41	2.31	3.08	3.33	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.80	27.30	3.56	2.14	2.37	1.90	0.24
frontal lobe, adult, pool1	10040-101F4	6.57	11.45	4.32	0.75	0.38	0.38	2.06
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	39.33	28.52	9.61	3.60	2.10	1.80	3.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	24.14	15.09	2.38	0.91	1.19	0.18	0.64
gall bladder, adult	10198-103E9	6.28	7.97	12.31	0.72	0.24	0.24	0.97
gamma delta positive T cells, donor1	11937-126A2	12.88	12.35	9.13	2.15	0.54	0.00	1.61
gamma delta positive T cells, donor2	11938-126A3	8.22	9.71	4.86	1.49	1.49	0.75	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.46	32.32	5.28	3.17	0.21	0.42	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.59	13.54	5.03	2.51	1.35	2.32	0.39
gastric cancer cell line:AZ521	10549-107H9	53.45	28.20	7.05	2.46	1.15	1.31	0.49
gastric cancer cell line:GSS	10560-108A2	72.30	43.93	2.75	0.92	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	55.52	18.28	6.63	1.60	5.71	3.20	1.37
giant cell carcinoma cell line:LU65	10487-107B1	46.47	18.01	0.69	1.49	1.61	1.61	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	17.49	18.47	4.62	0.42	0.28	0.42	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	22.45	14.47	4.49	0.00	1.00	1.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.68	14.04	2.96	1.48	0.84	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	17.98	12.78	1.54	1.12	1.12	0.42	0.14
glioblastoma cell line:T98G	10485-107A8	21.41	12.03	4.75	1.43	0.66	1.21	0.44
glioma cell line:GI-1	10413-106B8	23.14	6.15	1.76	0.59	0.88	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	2.19	5.83	5.10	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	4.39	5.37	10.74	0.00	0.24	0.00	1.46
globus pallidus, adult, donor10258	10367-105F7	2.74	4.11	0.00	0.00	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	4.26	4.26	6.40	0.00	0.53	2.13	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	4.89	2.45	22.02	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	20.91	0.00	0.00	10.45	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	11.20	4.80	2.24	1.28	0.96	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	59.23	32.60	2.30	2.30	0.92	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	45.27	26.98	2.29	1.83	0.00	1.37	0.91
hIPS +CCl2, biol_rep3	14385-156C2	58.61	25.12	2.58	0.64	5.15	3.22	1.29
hIPS, biol_rep1	14380-156B6	80.49	31.62	1.44	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	63.10	26.06	1.37	2.74	4.80	3.43	0.00
hIPS, biol_rep3	14382-156B8	13.24	13.24	1.10	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	53.45	31.32	4.88	2.87	1.44	1.72	0.57
heart - mitral valve, adult	10205-103F7	2.39	2.99	4.48	0.30	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	3.40	1.05	6.28	0.26	0.78	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	11.66	8.33	10.82	0.00	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	31.22	18.98	5.51	1.02	1.02	0.41	1.02
heart, adult, diseased, donor1	10051-101G6	2.55	7.66	4.26	0.85	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	3.68	4.83	3.22	0.00	0.23	0.00	0.23
heart, fetal, pool1	10046-101G1	9.86	6.88	8.01	0.72	1.13	0.92	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.65	5.86	2.78	0.31	0.62	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	9.51	4.76	3.57	0.00	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.71	11.82	8.73	1.44	1.99	2.98	1.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	35.81	11.65	8.62	2.06	1.70	2.91	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.85	10.91	10.71	1.52	2.83	2.63	2.02
hepatoma cell line:Li-7	10484-107A7	15.79	4.56	1.78	1.11	0.00	0.56	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	111.86	33.67	4.52	5.13	3.72	3.42	0.10
hippocampus - adult, donor10196	10169-103B7	4.73	5.68	4.73	0.95	0.95	0.00	2.84
hippocampus, adult, donor10252	10153-102I9	7.76	5.71	8.98	0.00	0.61	0.20	1.63
hippocampus, adult, donor10258	10374-105G5	6.47	5.48	1.49	0.50	0.50	1.00	1.99
hippocampus, newborn, donor10223	10363-105F3	3.88	7.75	2.82	1.76	0.35	0.35	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	115.97	75.07	9.16	7.32	5.49	1.22	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	61.46	37.90	8.44	3.53	3.14	1.18	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	65.51	53.06	5.08	5.08	3.05	1.02	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	14.66	20.86	10.15	1.13	2.26	1.69	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	19.37	21.17	7.75	1.03	2.32	1.03	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	17.08	35.30	10.63	1.52	0.76	0.76	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.80	12.26	16.35	0.88	3.80	0.88	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	12.93	15.73	16.16	1.08	1.94	1.72	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	8.34	10.84	15.01	0.83	2.50	0.42	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.81	13.26	13.50	1.18	0.95	1.89	3.08
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	15.27	12.70	10.77	1.29	2.73	1.77	5.46
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.77	10.10	10.77	2.02	3.37	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	62.75	38.65	5.48	2.35	2.35	2.35	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	80.08	35.86	5.90	6.88	6.88	1.97	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	121.31	72.44	2.62	2.62	10.47	4.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	13.94	16.42	8.21	0.95	1.72	0.38	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.47	14.39	7.85	0.44	2.18	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	14.49	27.99	9.50	2.00	4.00	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	16.01	27.88	11.68	2.64	3.77	2.83	3.77
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.46	33.65	12.28	1.82	6.37	2.27	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	13.78	31.95	12.84	2.19	5.95	2.19	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.63	15.19	9.14	1.14	0.49	0.33	2.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.29	14.23	8.71	0.58	2.61	0.00	4.06
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.66	16.14	8.37	1.20	1.20	1.20	2.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	54.50	35.29	7.21	2.96	2.96	2.96	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	49.35	35.09	5.99	3.71	3.14	1.14	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	80.03	72.27	8.57	4.49	3.67	2.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	16.90	25.70	8.10	0.70	3.17	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	13.62	21.54	6.97	1.90	1.58	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	17.55	23.30	7.57	1.51	1.51	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.27	11.89	10.34	0.52	2.07	2.07	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	18.60	17.93	2.66	0.66	0.66	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	6.93	11.29	11.03	0.26	2.31	1.03	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	15.34	13.29	7.16	0.77	1.53	1.28	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	15.14	6.06	0.00	1.51	3.03	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.43	17.14	7.06	0.34	2.02	1.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	51.20	34.29	8.69	4.59	2.17	1.93	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	61.95	54.37	9.80	4.46	2.23	4.01	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	55.12	54.15	10.24	3.90	1.95	2.93	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.61	22.92	11.31	1.53	1.83	1.83	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	81.33	165.92	0.00	9.76	13.01	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	26.81	37.73	10.26	1.99	2.65	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	11.49	16.42	16.42	0.55	1.64	1.09	2.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	15.56	14.84	13.39	0.00	2.17	1.81	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	10.68	22.42	14.23	1.42	2.49	1.07	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	19.09	14.32	8.35	0.00	2.39	0.00	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.71	16.12	13.81	1.76	2.17	1.08	5.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	10.78	12.66	9.97	1.62	1.08	0.54	3.23
immature langerhans cells, donor1	11904-125F5	5.81	5.09	0.73	0.48	0.48	0.00	0.24
immature langerhans cells, donor2	11905-125F6	2.38	4.75	2.38	0.79	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	9.56	11.45	4.73	1.61	0.95	0.66	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	36.42	13.98	10.40	1.63	0.98	0.33	1.63
kidney, adult, pool1	10017-101C8	11.21	15.42	9.11	0.90	0.60	0.50	0.70
kidney, fetal, pool1	10045-101F9	13.51	15.70	14.08	1.20	1.06	0.99	1.27
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.51	8.10	3.27	0.14	0.43	0.71	2.41
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.71	6.22	2.49	0.69	1.24	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	14.68	10.64	4.59	0.55	0.37	0.18	0.37
left atrium, adult, donor1	10079-102A7	9.26	4.36	1.63	0.00	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	4.05	6.07	0.51	1.52	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	29.82	17.78	4.38	0.55	0.55	0.27	0.82
leiomyoma cell line:10964C	10569-108B2	7.90	9.34	2.51	1.08	0.36	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	7.07	10.87	3.26	1.09	0.00	1.09	0.00
leiomyoma cell line:15425	10571-108B4	8.26	4.61	1.94	0.24	0.73	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	19.87	9.41	1.05	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	39.55	15.94	4.49	0.71	2.83	3.31	0.24
liposarcoma cell line:KMLS-1	10782-110G8	11.56	5.94	2.19	0.62	0.00	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	10.48	5.73	5.48	0.37	0.73	1.46	0.61
liver, adult, pool1	10018-101C9	20.91	10.53	3.08	1.30	0.49	0.65	0.00
liver, fetal, pool1	10086-102B5	11.29	5.64	2.82	0.94	1.88	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	2.33	3.06	4.08	0.15	0.29	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	4.80	4.80	11.26	0.74	0.55	0.18	1.11
locus coeruleus, adult, donor10258	10375-105G6	2.54	9.31	2.26	1.13	0.28	0.28	1.13
locus coeruleus, newborn, donor10223	10362-105F2	12.20	12.62	2.10	0.84	0.84	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.78	2.63	1.11	0.83	0.14	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	14.48	6.20	1.38	1.38	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.44	20.43	8.04	2.24	0.79	0.13	1.19
lung, adult, pool1	10019-101D1	7.91	3.54	6.97	0.24	0.24	0.12	0.12
lung, fetal, donor1	10068-101I5	15.41	9.42	12.84	0.29	1.14	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	3.67	4.58	4.12	0.46	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	8.52	7.10	3.31	0.95	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	53.04	11.40	2.63	1.97	1.32	1.10	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	45.58	15.09	0.75	2.11	3.77	4.53	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	28.03	28.03	4.25	2.55	0.00	1.70	0.00
mature adipocyte, donor1	12231-129F8	5.77	10.66	1.78	0.00	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	5.40	5.60	1.66	1.25	0.42	0.00	0.42
mature adipocyte, donor3	12233-129G1	6.16	4.27	1.66	0.95	0.24	0.00	0.47
mature adipocyte, donor4	12234-129G2	7.11	3.69	2.11	1.05	0.00	0.26	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	36.45	24.30	6.19	1.43	1.91	1.43	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	4.51	7.90	0.00	2.26	3.38	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	8.46	6.62	7.54	0.92	0.37	0.18	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	6.35	10.48	0.64	0.64	1.91	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	18.77	20.90	1.71	1.71	2.13	2.13	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	4.73	9.11	3.71	1.01	0.68	0.51	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	5.31	4.67	10.82	1.06	0.85	0.21	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	11.56	19.26	3.85	0.00	3.85	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	6.46	12.20	3.23	0.36	1.44	0.72	2.51
medulla oblongata - adult, donor10196	10174-103C3	5.19	7.14	4.54	0.65	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	4.49	4.18	6.81	0.15	0.31	0.15	0.93
medulla oblongata, adult, pool1	10038-101F2	3.18	6.45	4.90	0.16	0.08	0.16	1.71
medulla oblongata, newborn, donor10223	10361-105F1	3.82	9.37	7.29	0.00	0.00	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	36.09	14.83	4.65	1.55	0.89	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	17.73	7.83	2.45	0.73	1.10	0.73	0.24
melanoma cell line:COLO 679	10514-107E1	19.26	9.06	2.59	1.58	0.57	0.57	0.43
melanoma cell line:G-361	10465-106H6	26.60	14.12	3.80	1.63	0.00	0.27	0.81
meningioma cell line:HKBMM	10691-109F7	18.63	6.15	3.80	1.09	0.36	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	50.23	22.91	5.29	1.76	8.81	7.93	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	36.55	43.29	2.07	3.11	3.37	1.81	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	39.89	15.65	4.30	1.53	1.99	1.99	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.54	6.36	1.27	1.27	0.91	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	30.23	5.80	2.48	1.66	1.66	0.83	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	17.56	4.64	2.25	0.28	0.28	0.70	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.03	5.78	3.85	0.96	0.39	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	13.19	5.55	0.69	0.00	0.00	0.69	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.98	6.18	2.06	0.34	0.17	0.34	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.07	6.67	2.65	0.46	0.46	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.07	11.27	2.12	1.06	0.66	0.93	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.96	9.99	2.57	1.76	0.27	0.41	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	27.31	9.39	4.27	1.00	0.57	0.43	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	7.90	6.26	1.65	0.66	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.64	11.48	4.15	1.94	1.80	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.74	11.17	2.09	2.09	1.05	1.05	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.87	12.66	2.25	1.02	0.82	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	10.42	3.95	2.88	0.72	0.72	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.17	10.24	3.41	0.31	1.14	0.41	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.77	7.52	2.51	1.37	0.46	0.68	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	35.24	20.56	3.78	5.03	3.78	2.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	24.96	8.07	3.44	1.34	1.34	0.75	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	21.18	6.39	4.99	0.96	0.53	0.61	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.20	3.68	2.95	0.00	0.74	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.45	8.01	3.43	1.43	1.14	0.57	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	21.05	13.05	2.53	2.95	1.26	2.53	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	2.28	2.74	0.91	0.00	1.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.53	6.14	0.26	1.79	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	10.73	4.71	2.09	1.31	1.57	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	9.55	7.09	1.23	0.62	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	13.42	4.71	2.12	0.47	1.41	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.58	5.08	1.35	0.34	1.35	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	10.61	4.72	1.18	0.39	3.14	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.83	6.49	0.46	0.93	1.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.40	4.04	3.17	0.58	0.58	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	9.82	6.02	3.35	0.45	0.89	0.45	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	13.22	6.97	1.44	1.20	0.72	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	7.33	7.33	0.73	0.00	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.71	5.37	1.34	0.67	1.01	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.10	4.91	2.05	0.00	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.87	6.44	1.29	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	0.00	5.47	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.39	6.82	2.60	0.32	0.65	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	2.91	0.00	0.00	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	9.60	10.13	0.53	1.07	0.53	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	10.63	4.91	0.82	0.00	0.82	0.00	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.99	5.44	1.55	1.94	1.55	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	4.20	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	8.94	1.99	0.99	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	19.07	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.23	7.71	1.19	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	7.31	3.66	1.22	2.44	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	11.40	6.33	1.90	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.90	6.21	1.03	1.03	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	10.75	2.15	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.00	8.96	1.63	0.00	1.22	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	27.81	8.74	0.79	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	28.89	7.66	2.36	1.18	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	29.30	11.53	1.25	1.87	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	10.69	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	7.10	2.37	3.55	2.37	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	20.54	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.85	7.57	1.38	2.07	0.00	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	12.37	13.85	1.98	0.00	1.48	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	4.49	7.85	1.12	0.00	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.27	13.36	2.54	1.91	1.91	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.67	7.66	1.61	1.21	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	15.26	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	2.53	0.00	3.80	0.00	2.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.96	3.64	0.61	0.61	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	4.52	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	6.59	0.82	0.82	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.49	10.52	2.18	0.79	0.60	0.60	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.28	7.79	2.60	0.97	0.97	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	10.19	1.02	1.02	1.02	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	8.51	6.96	3.09	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.84	11.34	5.20	1.18	1.18	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.01	13.44	6.26	0.70	2.32	3.48	1.39
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	29.92	4.27	4.27	0.00	0.00	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	84.87	36.48	3.60	4.11	2.26	2.16	1.44
mesothelioma cell line:Mero-25	10850-111F4	9.53	7.26	3.63	0.68	0.45	0.45	3.86
mesothelioma cell line:Mero-41	10851-111F5	22.98	27.38	4.40	2.93	0.73	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	10.85	8.64	1.55	0.89	0.66	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	17.87	7.62	4.99	1.05	0.79	0.79	1.31
mesothelioma cell line:Mero-83	10854-111F8	19.58	9.70	3.23	1.19	0.68	0.17	0.85
mesothelioma cell line:Mero-84	10855-111F9	41.96	24.77	2.02	1.77	1.26	0.51	0.25
mesothelioma cell line:Mero-95	10856-111G1	15.32	6.21	4.55	0.62	1.24	0.62	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	16.23	14.25	1.99	0.66	0.99	0.83	0.33
mesothelioma cell line:NCI-H226	10846-111E9	14.12	11.04	3.26	0.36	0.72	1.09	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	22.38	13.67	4.27	1.02	1.02	1.37	0.85
mesothelioma cell line:NCI-H28	10845-111E8	37.41	19.85	3.05	1.78	3.31	1.78	0.25
mesothelioma cell line:No36	10857-111G2	35.23	21.20	0.98	2.28	1.30	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	32.24	17.34	2.17	1.63	1.08	0.81	0.81
migratory langerhans cells, donor1	11901-125F2	11.90	13.43	1.34	1.15	0.58	0.96	0.19
migratory langerhans cells, donor2	11902-125F3	8.30	5.50	1.83	0.73	0.49	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	10.59	6.46	2.87	1.08	0.00	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	12.73	10.45	3.59	0.65	0.98	0.00	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	46.63	13.35	1.06	2.12	4.87	3.81	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.72	11.29	3.46	1.38	0.00	0.23	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.97	14.46	1.14	2.09	0.57	2.09	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	116.05	33.45	5.91	5.54	5.36	5.91	0.92
myeloma cell line:PCM6	10474-106I6	28.07	21.15	1.19	2.57	0.79	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	6.09	1.52	0.51	0.51	0.51	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.61	5.30	2.94	1.18	0.59	0.98	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	6.13	9.47	3.57	0.56	0.11	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	6.91	11.03	2.50	0.37	0.07	0.00	0.07
nasal epithelial cells, donor2	12227-129F4	7.73	10.49	2.21	0.55	0.00	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	34.97	17.94	4.14	1.84	3.68	5.52	0.23
neuroblastoma cell line:NB-1	10539-107G8	42.28	17.02	4.68	2.81	3.74	1.12	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	25.10	20.67	5.06	1.27	1.27	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	45.10	19.19	8.76	2.05	3.35	2.98	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.15	10.68	3.80	0.95	2.37	1.66	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	14.73	21.22	3.96	0.63	1.43	0.32	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	78.29	39.65	6.84	3.62	1.01	1.81	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	17.17	24.16	2.54	0.00	0.64	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	10.38	3.46	1.60	0.53	1.60	0.80	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	19.79	13.36	4.06	2.20	4.90	7.44	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	81.65	59.24	2.40	4.00	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	14.43	8.66	4.49	1.28	1.28	1.28	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.82	6.57	2.89	0.79	0.26	0.79	1.05
nucleus accumbens, adult, pool1	10037-101F1	5.25	9.84	4.78	0.75	0.37	0.56	1.22
occipital cortex - adult, donor10196	10172-103C1	4.12	6.18	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	4.83	6.17	11.81	0.27	0.81	0.27	1.34
occipital cortex, newborn, donor10223	10355-105E4	6.91	9.83	4.00	0.36	0.00	1.46	0.73
occipital lobe, adult, donor1	10076-102A4	6.56	10.76	1.57	1.57	0.52	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	13.30	11.16	3.43	0.00	1.29	1.29	0.43
occipital pole, adult, pool1	10036-101E9	6.39	13.09	3.78	0.47	0.63	0.47	0.79
olfactory region, adult	10195-103E6	5.35	7.83	3.44	1.15	0.38	0.76	1.15
optic nerve, donor1	10277-104E7	2.00	2.00	10.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	38.61	12.30	6.38	1.48	1.94	1.48	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	60.59	31.32	5.63	2.75	2.47	1.65	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.10	8.80	1.86	0.68	0.68	0.51	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.85	11.90	4.50	1.50	1.04	1.62	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	10.88	5.29	0.88	0.29	1.18	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	17.75	13.08	0.93	0.93	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	19.72	8.06	5.73	0.00	2.33	1.27	1.27
ovary, adult, pool1	10020-101D2	6.73	4.80	10.31	0.44	0.44	0.44	0.87
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	22.55	11.73	2.57	1.28	2.02	1.47	0.00
pancreas, adult, donor1	10049-101G4	25.40	14.11	7.53	0.94	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	36.06	19.29	4.19	1.40	1.12	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	23.51	15.50	3.75	0.68	1.19	0.51	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	24.51	13.74	3.48	2.15	0.00	0.33	0.66
paracentral gyrus, adult, pool1	10035-101E8	6.96	13.82	4.48	1.01	0.82	0.46	0.82
parietal cortex, adult, donor10258	10373-105G4	3.67	9.54	1.47	0.00	0.73	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	6.58	11.29	0.94	0.94	0.94	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	8.84	6.27	6.84	0.86	0.29	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	7.58	12.51	6.26	1.06	0.53	0.53	0.62
parietal lobe, fetal, donor1	10072-101I9	9.70	14.55	4.85	1.94	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	6.73	11.22	2.99	0.75	1.50	1.12	1.87
parotid gland, adult	10199-103F1	7.40	11.10	0.62	1.23	0.62	0.00	0.62
penis, adult	10200-103F2	2.69	2.15	14.50	0.54	1.61	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	12.27	8.18	3.16	0.37	0.37	0.37	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.56	13.84	4.08	1.17	1.89	1.31	1.75
pineal gland - adult, donor10196	10179-103C8	3.23	3.23	5.16	1.29	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	7.70	8.88	7.70	2.37	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	5.64	5.64	3.76	0.63	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	23.27	6.07	5.06	2.02	2.02	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	20.33	6.78	15.11	3.65	0.00	0.52	0.52
pituitary gland, adult, donor10258	10378-105G9	13.62	10.21	8.51	0.00	0.85	3.40	0.85
placenta, adult, pool1	10021-101D3	9.35	11.18	4.62	0.86	1.08	0.43	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	49.66	17.88	1.99	1.32	3.31	3.71	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.92	9.96	4.20	0.47	0.62	1.09	0.31
pons, adult, pool1	10033-101E6	4.30	10.59	4.13	0.69	0.26	0.26	0.86
postcentral gyrus, adult, pool1	10032-101E5	8.63	13.43	4.27	1.13	0.61	0.17	1.13
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	2.09	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	5.51	5.51	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	35.21	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	48.21	37.87	5.10	2.77	2.18	0.87	0.73
prostate cancer cell line:PC-3	10439-106E7	63.16	32.85	5.26	5.45	1.82	2.00	1.09
prostate, adult, pool1	10022-101D4	5.80	4.44	8.25	0.09	0.36	0.09	0.18
putamen, adult, donor10196	10176-103C5	2.60	6.61	4.25	0.71	0.24	0.24	1.18
putamen, adult, donor10252	10152-102I8	0.00	5.88	5.88	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	14.21	2.19	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	1.45	7.49	2.17	0.48	0.24	0.00	0.24
putamen, newborn, donor10223	10365-105F5	9.75	10.50	1.50	0.00	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	18.62	5.24	5.53	0.58	0.58	0.58	0.58
rectum, fetal, donor1	10067-101I4	6.95	9.74	48.68	0.00	0.00	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	23.53	20.35	3.60	2.12	2.12	1.06	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	51.36	29.82	5.80	1.66	2.90	1.66	0.83
retina, adult, pool1	10030-101E3	6.96	7.36	10.44	0.50	0.50	0.30	1.59
retinoblastoma cell line:Y79	10475-106I7	72.48	35.85	2.86	4.16	4.94	3.90	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	25.82	15.37	4.06	1.60	0.61	0.86	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	45.55	32.90	5.06	4.22	0.28	0.56	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	3.79	0.76	2.27	2.27	0.76	0.00	0.76
salivary acinar cells, donor1	11771-123I7	16.35	9.23	3.88	0.49	0.16	0.00	0.32
salivary acinar cells, donor2	11772-123I8	9.36	7.44	6.06	0.83	0.00	0.28	0.28
salivary acinar cells, donor3	11773-123I9	1.32	4.63	4.63	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	14.87	16.59	4.00	2.29	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.73	8.09	4.05	0.59	0.42	0.08	1.10
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	13.52	8.23	7.05	0.82	0.59	0.24	1.18
seminal vesicle, adult	10201-103F3	3.17	4.23	7.94	0.53	0.53	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	22.59	18.22	10.93	1.46	1.46	0.49	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	14.34	13.59	2.26	0.25	0.50	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	16.06	6.02	3.01	3.01	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.92	40.83	8.46	1.75	0.40	0.40	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	25.20	21.11	1.66	1.33	1.55	1.66	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	68.90	29.55	8.39	3.48	1.55	2.06	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	2.13	0.71	0.00	1.42	2.84	0.00
skeletal muscle, adult, pool1	10023-101D5	8.76	7.92	2.76	1.56	0.48	0.48	0.36
skeletal muscle, fetal, donor1	10066-101I3	16.08	7.04	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	8.84	11.99	7.57	0.00	1.89	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	36.69	32.02	7.00	4.00	2.67	3.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	75.96	24.90	12.29	3.47	3.47	0.95	2.21
small cell lung carcinoma cell line:DMS 144	10841-111E4	37.97	32.38	3.47	2.12	2.89	1.35	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	58.84	45.82	6.26	4.45	2.47	3.79	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	94.90	64.82	4.83	4.02	1.93	2.09	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	40.31	24.84	12.20	3.05	1.09	0.65	1.31
small intestine, adult, pool1	10024-101D6	8.84	10.87	21.74	0.60	0.24	0.24	0.60
small intestine, fetal, donor1	10064-101I1	12.28	8.11	15.48	0.25	0.98	0.25	2.21
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	33.34	31.29	2.56	1.03	2.05	2.56	0.51
smooth muscle, adult, pool1	10048-101G3	4.14	2.84	9.05	0.00	0.00	0.26	1.03
somatostatinoma cell line:QGP-1	10781-110G7	13.94	8.31	1.34	0.80	0.80	1.88	0.80
spinal cord - adult, donor10196	10181-103D1	0.92	2.29	2.98	0.46	0.46	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	4.73	3.55	4.34	0.00	0.00	0.39	1.58
spinal cord, adult, donor10258	10369-105F9	3.46	2.77	2.77	0.00	0.00	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	10.98	8.54	9.15	0.61	0.00	1.22	1.22
spinal cord, newborn, donor10223	10359-105E8	9.64	6.43	4.13	0.00	0.46	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	12.55	5.68	1.49	0.90	0.75	0.90	0.45
spleen, adult, pool1	10025-101D7	11.12	4.85	5.40	0.55	1.32	0.66	0.11
spleen, fetal, pool1	10044-101F8	11.04	5.88	9.93	0.87	0.64	0.48	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	62.31	25.98	1.04	4.24	2.28	3.21	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.08	10.63	5.13	1.33	1.14	1.71	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	58.01	39.84	8.04	4.19	1.75	1.40	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	45.74	25.02	3.13	1.56	3.13	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	33.99	13.39	9.34	0.68	2.81	2.14	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	136.40	57.61	3.81	5.51	8.47	6.35	1.27
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	41.88	11.00	4.23	1.69	1.27	0.85	1.27
stomach, fetal, donor1	10062-101H8	18.16	18.16	6.41	1.07	0.00	1.07	1.07
submaxillary gland, adult	10202-103F4	5.13	7.41	2.28	0.57	0.57	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	4.78	3.74	9.14	0.42	0.21	0.21	0.83
substantia nigra, adult, donor10258	10371-105G2	2.59	4.66	0.52	0.00	1.03	1.03	1.03
substantia nigra, newborn, donor10223	10358-105E7	5.65	6.36	4.24	1.41	0.71	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	23.16	18.57	2.52	2.29	0.69	1.60	0.23
temporal lobe, adult, pool1	10031-101E4	6.61	13.82	4.49	1.19	0.59	0.42	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	9.26	14.96	7.83	0.00	0.71	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	9.67	8.79	4.40	0.44	2.64	0.88	0.88
tenocyte, donor1	11763-123H8	19.90	5.24	4.89	0.35	0.70	0.35	0.00
tenocyte, donor2	11765-123I1	19.46	6.49	11.83	0.38	0.38	0.38	0.76
tenocyte, donor3	11768-123I4	18.53	9.64	4.82	1.48	1.48	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	93.82	50.14	8.16	4.59	4.76	2.72	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	60.27	28.98	11.56	3.24	0.62	1.39	1.39
teratocarcinoma cell line:PA-1	10807-111A6	43.24	31.62	4.49	2.17	1.39	0.77	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	30.21	34.28	3.05	3.05	0.63	0.63	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	40.09	34.04	13.61	1.51	1.51	1.13	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.88	19.52	3.93	1.42	0.44	0.44	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	27.68	44.62	7.17	2.61	2.93	1.63	0.65
testis, adult, pool1	10026-101D8	11.17	19.97	3.76	2.90	0.43	0.21	0.00
testis, adult, pool2	10096-102C6	12.18	18.95	3.61	1.80	1.35	2.71	0.00
thalamus - adult, donor10196	10168-103B6	0.00	4.42	5.52	0.00	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	4.84	2.97	8.91	0.00	0.31	0.00	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	3.08	7.70	1.54	0.00	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	2.31	4.78	2.80	0.00	0.49	0.49	1.65
thalamus, newborn, donor10223	10366-105F6	4.03	10.93	2.88	0.58	0.00	1.73	0.58
throat, adult	10209-103G2	4.99	6.24	4.99	0.25	0.75	0.50	0.50
throat, fetal, donor1	10061-101H7	7.62	6.09	8.23	0.91	0.61	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	49.68	23.85	5.37	3.78	3.38	4.57	0.00
thymus, adult, pool1	10027-101D9	13.22	16.20	1.89	0.40	1.89	1.39	0.20
thymus, fetal, pool1	10043-101F7	11.74	14.75	6.13	0.62	0.94	1.66	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	32.58	12.37	3.86	1.46	1.60	1.06	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	50.29	25.42	6.43	2.65	2.24	3.07	0.98
thyroid, adult, pool1	10028-101E1	13.34	12.04	10.92	0.65	0.47	0.28	0.09
thyroid, fetal, donor1	10060-101H6	5.01	5.80	11.34	1.05	0.79	0.26	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	0.00	3.08	9.24	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	7.91	9.54	3.72	0.47	0.47	0.70	0.47
tongue, fetal, donor1	10059-101H5	12.22	13.79	8.67	0.00	1.58	0.39	0.39
tonsil, adult, pool1	10047-101G2	14.73	12.22	7.11	0.80	0.20	0.80	0.40
trachea, adult, pool1	10029-101E2	13.01	9.24	6.05	1.39	0.65	0.65	0.25
trachea, fetal, donor1	10058-101H4	9.62	7.31	10.00	0.77	0.38	1.15	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.11	7.79	1.77	0.71	0.71	0.35	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	25.94	14.39	2.74	1.22	0.91	1.01	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	71.29	24.60	7.83	2.66	2.19	2.35	1.57
tridermal teratoma cell line:HGRT	10694-109G1	1.90	3.81	1.90	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.00	7.11	5.76	0.76	0.85	0.85	0.68
umbilical cord, fetal, donor1	10057-101H3	18.78	10.43	6.26	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	7.68	5.46	13.48	0.85	0.34	0.00	0.00
uterus, fetal, donor1	10055-101H1	8.70	9.73	13.31	1.02	1.54	2.05	0.00
vagina, adult	10204-103F6	1.94	1.94	9.05	0.00	0.00	0.00	1.29
vein, adult	10191-103E2	6.58	3.95	6.14	0.22	0.44	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.70	8.81	2.67	1.87	1.34	0.27	0.00